Relationship	O
between	O
Rap1	B-protein
protein	I-protein
phosphorylation	O
and	O
regulation	O
of	O
Ca2+	O
transport	O
in	O
platelets	B-cell_type
:	O
a	O
new	O
approach	O
.	O

Although	O
the	O
interrelationship	O
between	O
the	O
two	O
messengers	O
Ca2+	O
and	O
cyclic	O
AMP	O
in	O
platelet	O
function	O
is	O
well	O
documented	O
,	O
its	O
mechanism	O
of	O
action	O
still	O
remains	O
to	O
be	O
established	O
.	O

We	O
investigated	O
here	O
the	O
question	O
of	O
the	O
regulation	O
of	O
platelet	B-protein
Ca	I-protein
(	I-protein
2+	I-protein
)	I-protein
-ATPases	I-protein
by	O
cyclic	O
AMP	O
through	O
the	O
phosphorylation	O
of	O
the	O
Rap1	B-protein
protein	I-protein
using	O
a	O
pathological	O
model	O
.	O

We	O
first	O
found	O
experimental	O
conditions	O
where	O
Ca	O
(	O
2+	O
)	O
-transport	O
by	O
platelet	O
membrane	O
vesicles	O
appeared	O
to	O
be	O
dependent	O
on	O
the	O
phosphorylation	O
of	O
the	O
Rap1	B-protein
protein	I-protein
.	O

Then	O
,	O
we	O
studied	O
platelets	B-cell_type
of	O
patients	O
with	O
congestive	O
heart	O
failure	O
for	O
their	O
expression	O
of	O
the	O
potential	O
97	B-protein
kDa	I-protein
Ca	I-protein
(	I-protein
2+	I-protein
)	I-protein
-ATPase	I-protein
target	I-protein
of	O
regulation	O
through	O
the	O
Rap1	B-protein
protein	I-protein
as	O
well	O
as	O
the	O
phosphorylation	O
of	O
the	O
Rap1	B-protein
protein	I-protein
using	O
the	O
catalytic	B-protein
subunit	I-protein
of	O
the	O
cyclic	B-protein
AMP-dependent	I-protein
protein	I-protein
kinase	I-protein
(	O
C.	B-protein
Sub	I-protein
.	I-protein
)	O
.	O

In	O
the	O
first	O
patients	O
studied	O
,	O
we	O
found	O
no	O
significant	O
modification	O
in	O
the	O
expression	O
of	O
the	O
97	B-protein
kDa	I-protein
Ca	I-protein
(	I-protein
2+	I-protein
)	I-protein
-ATPase	I-protein
by	O
Western	O
blotting	O
using	O
the	O
PL/IM	B-protein
430	I-protein
monoclonal	I-protein
antibody	I-protein
which	O
specifically	O
recognized	O
this	O
isoform	O
.	O

In	O
contrast	O
,	O
the	O
Rap1	B-protein
protein	I-protein
was	O
differentially	O
phosphorylated	O
when	O
using	O
15	O
micrograms/ml	O
of	O
the	O
C.	B-protein
Sub	I-protein
.	I-protein

These	O
results	O
allowed	O
us	O
to	O
use	O
these	O
pathological	O
platelets	B-cell_type
to	O
study	O
the	O
relationship	O
between	O
the	O
expression	O
of	O
Rap1	B-protein
protein	I-protein
and	O
the	O
regulation	O
of	O
Ca2+	O
transport	O
by	O
selecting	O
a	O
patient	O
with	O
severe	O
heart	O
failure	O
.	O

We	O
could	O
show	O
a	O
decrease	O
in	O
the	O
expression	O
as	O
well	O
as	O
in	O
the	O
phosphorylation	O
of	O
Rap1	B-protein
protein	I-protein
and	O
demonstrate	O
a	O
lower	O
effect	O
of	O
C.	B-protein
Sub	I-protein
.	I-protein
on	O
Ca2+	O
transport	O
.	O

Finally	O
,	O
by	O
studying	O
a	O
further	O
series	O
of	O
patients	O
,	O
we	O
could	O
confirm	O
that	O
the	O
decrease	O
in	O
Rap1	B-protein
protein	I-protein
expression	O
in	O
heart	O
failure	O
,	O
whatever	O
its	O
extent	O
,	O
was	O
variable	O
,	O
and	O
could	O
strictly	O
correlate	O
the	O
expression	O
of	O
Rap1	B-protein
protein	I-protein
with	O
the	O
stimulatory	O
effect	O
of	O
C.	B-protein
Sub	I-protein
.	I-protein
on	O
Ca2+	O
transport	O
.	O

Besides	O
the	O
evidence	O
for	O
regulation	O
of	O
the	O
expression	O
of	O
the	O
Rap1	B-protein
protein	I-protein
in	O
platelets	B-cell_type
from	O
patients	O
with	O
heart	O
failure	O
,	O
these	O
findings	O
constitute	O
a	O
new	O
approach	O
in	O
favour	O
of	O
the	O
regulation	O
of	O
platelet	O
Ca2+	O
transport	O
through	O
the	O
phosphorylation	O
of	O
the	O
Rap1	B-protein
protein	I-protein
.	O

Biochem	NULL
.	NULL

J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
310	NULL
,	NULL
469-475	NULL
(	NULL
Printed	NULL
in	NULL
Great	NULL
Britain	NULL
)	NULL
469	NULL
Relationship	NULL
between	NULL
Rap1	NULL
protein	NULL
phosphorylation	NULL
and	NULL
regulation	NULL
of	NULL
Ca	NULL
#	NULL
+	NULL
transport	NULL
in	NULL
platelets	NULL
:	NULL
a	NULL
new	NULL
approach	NULL
Clarice	NULL
MAGNIER	NULL
,	NULL
*§	NULL
Elisabeth	NULL
CORVAZIER	NULL
,	NULL
*	NULL
Marie-Claude	NULL
AUMONT	NULL
,	NULL
f	NULL
Thierry	NULL
H.	NULL
LE	NULL
JEMTEL	NULL
$	NULL
and	NULL
Jocelyne	NULL
ENOUF*	NULL
*U	NULL
.	NULL

348	NULL
INSERM	NULL
,	NULL
8	NULL
Rue	NULL
Guy	NULL
Patin	NULL
,	NULL
Hopital	NULL
Lariboisigre	NULL
,	NULL
75010	NULL
Paris	NULL
,	NULL
France	NULL
,	NULL
Hopital	NULL
Bichat	NULL
,	NULL
46	NULL
Rue	NULL
Henri	NULL
Huchard	NULL
,	NULL
75018	NULL
Paris	NULL
,	NULL
France	NULL
,	NULL
and	NULL
fAlbert	NULL
Einstein	NULL
College	NULL
of	NULL
Medicine	NULL
of	NULL
Yeshiva	NULL
University	NULL
,	NULL
Department	NULL
of	NULL
Medicine/Cardiology	NULL
,	NULL
1300	NULL
Morris	NULL
Park	NULL
Avenue	NULL
,	NULL
NY	NULL
10641	NULL
,	NULL
U.S.A	NULL
.	NULL

Although	NULL
the	NULL
interrelationship	NULL
between	NULL
the	NULL
two	NULL
messengers	NULL
Ca**	NULL
and	NULL
cyclic	NULL
AMP	NULL
in	NULL
platelet	NULL
function	NULL
is	NULL
well	NULL
documented	NULL
,	NULL
its	NULL
mechanism	NULL
of	NULL
action	NULL
still	NULL
remains	NULL
to	NULL
be	NULL
established	NULL
.	NULL

We	NULL
investigated	NULL
here	NULL
the	NULL
question	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
platelet	NULL
Ca**-ATPases	NULL
by	NULL
cyclic	NULL
AMP	NULL
through	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
Rapl	NULL
protein	NULL
using	NULL
a	NULL
pathological	NULL
model	NULL
.	NULL

We	NULL
first	NULL
found	NULL
experimental	NULL
conditions	NULL
where	NULL
Ca**	NULL
transport	NULL
by	NULL
platelet	NULL
membrane	NULL
vesicles	NULL
appeared	NULL
to	NULL
be	NULL
dependent	NULL
on	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
Rapl	NULL
protein	NULL
.	NULL

Then	NULL
,	NULL
we	NULL
studied	NULL
platelets	NULL
of	NULL
patients	NULL
with	NULL
congestive	NULL
heart	NULL
failure	NULL
for	NULL
their	NULL
expression	NULL
of	NULL
the	NULL
potential	NULL
97	NULL
kDa	NULL
Ca**-ATPase	NULL
target	NULL
of	NULL
regulation	NULL
through	NULL
the	NULL
Rapl	NULL
protein	NULL
as	NULL
well	NULL
as	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
Rapl	NULL
protein	NULL
using	NULL
the	NULL
catalytic	NULL
subunit	NULL
of	NULL
the	NULL
cyclic	NULL
AMP-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
C	NULL
.	NULL

Sub	NULL
.	NULL
)	NULL

.	NULL

In	NULL
the	NULL
first	NULL
patients	NULL
studied	NULL
,	NULL
we	NULL
found	NULL
no	NULL
significant	NULL
modification	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
97	NULL
kDa	NULL
Ca**-ATPase	NULL
by	NULL
Western	NULL
blotting	NULL
using	NULL
the	NULL
PL/IM	NULL
430	NULL
monoclonal	NULL
antibody	NULL
which	NULL
specifically	NULL
recognized	NULL
this	NULL
isoform	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
Rapl	NULL
protein	NULL
was	NULL
differentially	NULL
phosphorylated	NULL
when	NULL
using	NULL
15	NULL
ug/ml	NULL
of	NULL
the	NULL
C.	NULL
Sub	NULL
.	NULL

These	NULL
results	NULL
allowed	NULL
us	NULL
to	NULL
use	NULL
these	NULL
pathological	NULL
platelets	NULL
to	NULL
study	NULL
the	NULL
relationship	NULL
between	NULL
the	NULL
expression	NULL
of	NULL
Rapl	NULL
protein	NULL
and	NULL
the	NULL
regulation	NULL
of	NULL
Ca**	NULL
transport	NULL
by	NULL
selecting	NULL
a	NULL
patient	NULL
with	NULL
severe	NULL
heart	NULL
failure	NULL
.	NULL

We	NULL
could	NULL
show	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
expression	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
Rapl	NULL
protein	NULL
and	NULL
demonstrate	NULL
a	NULL
lower	NULL
effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

on	NULL
Ca®*	NULL
transport	NULL
.	NULL

Finally	NULL
,	NULL
by	NULL
studying	NULL
a	NULL
further	NULL
series	NULL
of	NULL
patients	NULL
,	NULL
we	NULL
could	NULL
confirm	NULL
that	NULL
the	NULL
decrease	NULL
in	NULL
Rapl	NULL
protein	NULL
expression	NULL
in	NULL
heart	NULL
failure	NULL
,	NULL
whatever	NULL
its	NULL
extent	NULL
,	NULL
was	NULL
variable	NULL
,	NULL
and	NULL
could	NULL
strictly	NULL
correlate	NULL
the	NULL
expression	NULL
of	NULL
Rapl	NULL
protein	NULL
with	NULL
the	NULL
stimulatory	NULL
effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

on	NULL
Ca**	NULL
transport	NULL
.	NULL

Besides	NULL
the	NULL
evidence	NULL
for	NULL
regulation	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
Rapl1	NULL
protein	NULL
in	NULL
platelets	NULL
from	NULL
patients	NULL
with	NULL
heart	NULL
failure	NULL
,	NULL
these	NULL
findings	NULL
constitute	NULL
a	NULL
new	NULL
approach	NULL
in	NULL
favour	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
platelet	NULL
Ca**	NULL
transport	NULL
through	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
Rapl	NULL
protein	NULL
.	NULL

INTRODUCTION	NULL
The	NULL
regulation	NULL
of	NULL
platelet	NULL
cytosolic	NULL
Ca**	NULL
concentration	NULL
involves	NULL
specific	NULL
and	NULL
opposite	NULL
mechanisms	NULL
depending	NULL
upon	NULL
whether	NULL
it	NULL
concerns	NULL
cell	NULL
activation	NULL
or	NULL
inhibition	NULL
.	NULL

Activation	NULL
of	NULL
platelets	NULL
by	NULL
different	NULL
physiological	NULL
stimuli	NULL
induces	NULL
transduction	NULL
signalling	NULL
processes	NULL
resulting	NULL
in	NULL
an	NULL
increase	NULL
in	NULL
cytosolic	NULL
Ca**	NULL
concentration	NULL
.	NULL

This	NULL
occurs	NULL
by	NULL
two	NULL
phenomena	NULL
:	NULL
Ca*	NULL
influx	NULL
from	NULL
extracellular	NULL
medium	NULL
through	NULL
calcium	NULL
channels	NULL
and	NULL
release	NULL
of	NULL
Ca**	NULL
ions	NULL
from	NULL
intracellular	NULL
Ca**	NULL
storage	NULL
pools	NULL
including	NULL
an	NULL
inositol	NULL
1,4,5-trisphosphate	NULL
(	NULL
InsP	NULL
,	NULL
)	NULL
-sensitive	NULL
Ca**	NULL
pool	NULL
and/or	NULL
an	NULL
InsP	NULL
,	NULL
-insensitive	NULL
Ca**	NULL
pool	NULL
[	NULL
1-4	NULL
]	NULL
.	NULL

Conversely	NULL
,	NULL
the	NULL
restoration	NULL
of	NULL
platelet	NULL
cytosolic	NULL
Ca**	NULL
concentration	NULL
associated	NULL
with	NULL
the	NULL
inhibition	NULL
of	NULL
platelet	NULL
function	NULL
,	NULL
i.e	NULL
.	NULL

the	NULL
return	NULL
to	NULL
a	NULL
basal	NULL
state	NULL
,	NULL
is	NULL
partly	NULL
mediated	NULL
by	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
multi-SERCA	NULL
(	NULL
SarcoEndoplasmic	NULL
Reticulum	NULL
Ca**-ATPase	NULL
)	NULL
system	NULL
which	NULL
decreases	NULL
cytosolic	NULL
Ca**	NULL
concentration	NULL
,	NULL
by	NULL
pumping	NULL
Ca®	NULL
ions	NULL
into	NULL
the	NULL
intracellular	NULL
Ca**	NULL
pools	NULL
.	NULL

One	NULL
of	NULL
these	NULL
Ca**-ATPases	NULL
was	NULL
identified	NULL
as	NULL
the	NULL
ubiquitous	NULL
SERCA	NULL
2-b	NULL
isoform	NULL
[	NULL
5	NULL
]	NULL
,	NULL
a	NULL
second	NULL
one	NULL
was	NULL
recently	NULL
shown	NULL
to	NULL
correspond	NULL
to	NULL
the	NULL
SERCA	NULL
3	NULL
isoform	NULL
[	NULL
6,7	NULL
]	NULL
,	NULL
whereas	NULL
a	NULL
third	NULL
one	NULL
was	NULL
recently	NULL
detected	NULL
,	NULL
specifically	NULL
recognized	NULL
by	NULL
a	NULL
platelet	NULL
monoclonal	NULL
antibody	NULL
termed	NULL
PL	NULL
/IM	NULL
430	NULL
,	NULL
but	NULL
which	NULL
still	NULL
remains	NULL
to	NULL
be	NULL
identified	NULL
[	NULL
8	NULL
]	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
their	NULL
own	NULL
activation	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
platelet	NULL
cytosolic	NULL
Ca®*	NULL
concentration	NULL
,	NULL
the	NULL
Ca®*-ATPases	NULL
were	NULL
suggested	NULL
to	NULL
be	NULL
up-regulated	NULL
through	NULL
cyclic	NULL
AMP	NULL
.	NULL

This	NULL
hypothesis	NULL
was	NULL
initially	NULL
based	NULL
on	NULL
the	NULL
observation	NULL
that	NULL
cyclic	NULL
AMP	NULL
inhibits	NULL
platelet	NULL
function	NULL
[	NULL
1	NULL
]	NULL
in	NULL
association	NULL
with	NULL
a	NULL
decrease	NULL
in	NULL
Ca**	NULL
concentration	NULL
.	NULL

This	NULL
might	NULL
be	NULL
a	NULL
consequence	NULL
of	NULL
multiple	NULL
sites	NULL
[	NULL
9,10	NULL
]	NULL
,	NULL
as	NULL
well	NULL
as	NULL
an	NULL
action	NULL
on	NULL
the	NULL
phospholipase	NULL
C	NULL
and/or	NULL
the	NULL
InsP	NULL
,	NULL
receptor	NULL
,	NULL
a	NULL
stimulation	NULL
of	NULL
Ca**	NULL
efflux	NULL
,	NULL
or	NULL
an	NULL
activation	NULL
of	NULL
Ca**-ATPases	NULL
,	NULL
the	NULL
latter	NULL
being	NULL
the	NULL
subject	NULL
of	NULL
the	NULL
present	NULL
study	NULL
.	NULL

Indeed	NULL
,	NULL
an	NULL
interesting	NULL
early	NULL
finding	NULL
was	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
cyclic	NULL
AMP	NULL
to	NULL
a	NULL
cytosolic	NULL
fraction	NULL
containing	NULL
cyclic	NULL
AMP-dependent	NULL
protein	NULL
kinase	NULL
stimulated	NULL
Ca**	NULL
transport	NULL
mediated	NULL
by	NULL
Ca**-ATPases	NULL
and	NULL
phosphorylated	NULL
a	NULL
22	NULL
kDa	NULL
protein	NULL
[	NULL
11	NULL
]	NULL
.	NULL

Various	NULL
authors	NULL
subsequently	NULL
confirmed	NULL
this	NULL
finding	NULL
,	NULL
using	NULL
different	NULL
approaches	NULL
.	NULL

First	NULL
,	NULL
Fox	NULL
et	NULL
al	NULL
.	NULL

treated	NULL
intact	NULL
platelets	NULL
with	NULL
agents	NULL
enhancing	NULL
the	NULL
cyclic	NULL
AMP	NULL
level	NULL
and	NULL
decreasing	NULL
the	NULL
cytosolic	NULL
Ca**	NULL
concentration	NULL
.	NULL

They	NULL
demonstrated	NULL
that	NULL
a	NULL
22	NULL
kDa	NULL
membrane	NULL
protein	NULL
was	NULL
phosphorylated	NULL
concomitantly	NULL
with	NULL
an	NULL
increase	NULL
in	NULL
Ca**	NULL
uptake	NULL
[	NULL
12	NULL
]	NULL
.	NULL

Second	NULL
,	NULL
this	NULL
effect	NULL
of	NULL
cyclic	NULL
AMP	NULL
on	NULL
both	NULL
the	NULL
phosphorylation	NULL
of	NULL
a	NULL
22	NULL
kDa	NULL
protein	NULL
and	NULL
Ca®**	NULL
uptake	NULL
was	NULL
further	NULL
confirmed	NULL
by	NULL
treating	NULL
isolated	NULL
membrane	NULL
vesicles	NULL
with	NULL
the	NULL
purified	NULL
catalytic	NULL
subunit	NULL
(	NULL
C	NULL
.	NULL

Sub	NULL
.	NULL
)	NULL

of	NULL
the	NULL
cyclic	NULL
AMP-dependent	NULL
protein	NULL
kinase	NULL
[	NULL
13,14	NULL
]	NULL
.	NULL

Many	NULL
years	NULL
later	NULL
,	NULL
the	NULL
cyclic	NULL
AMP-phosphoprotein	NULL
was	NULL
identified	NULL
as	NULL
a	NULL
small	NULL
GTP-binding	NULL
protein	NULL
of	NULL
the	NULL
Ras	NULL
family	NULL
,	NULL
a	NULL
Rapl	NULL
protein	NULL
,	NULL
more	NULL
precisely	NULL
the	NULL
Rap1B	NULL
[	NULL
15-17	NULL
]	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
were	NULL
recently	NULL
able	NULL
to	NULL
suggest	NULL
that	NULL
the	NULL
Ca**-ATPase	NULL
target	NULL
of	NULL
the	NULL
regulation	NULL
through	NULL
the	NULL
Rap1lB	NULL
protein	NULL
would	NULL
strictly	NULL
involve	NULL
the	NULL
97	NULL
kDa	NULL
isoform	NULL
recognized	NULL
by	NULL
the	NULL
PL/IM	NULL
430	NULL
antibody	NULL
,	NULL
among	NULL
the	NULL
above-defined	NULL
platelet	NULL
multi-SERCA	NULL
system	NULL
[	NULL
18	NULL
]	NULL
.	NULL

However	NULL
,	NULL
during	NULL
these	NULL
studies	NULL
,	NULL
some	NULL
controversy	NULL
was	NULL
raised	NULL
about	NULL
this	NULL
effect	NULL
of	NULL
Rapl	NULL
protein	NULL
on	NULL
platelet	NULL
Ca**	NULL
transport	NULL
,	NULL
based	NULL
on	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
C.	NULL
Sub	NULL
.	NULL

effect	NULL
could	NULL
be	NULL
Abbreviations	NULL
used	NULL
:	NULL
C	NULL
.	NULL

Sub	NULL
.	NULL

,	NULL
catalytic	NULL
subunit	NULL
of	NULL
the	NULL
cyclic	NULL
AMP-dependent	NULL
protein	NULL
kinase	NULL
;	NULL
Rap	NULL
,	NULL
Ras-proximate	NULL
;	NULL
SERCA	NULL
,	NULL
sarcoendoplasmic	NULL
reticulum	NULL
Ca®*-ATPase	NULL
;	NULL
InsP	NULL
,	NULL
inositol	NULL
1,4,5-trisphosphate	NULL
;	NULL
PL/IM	NULL
430	NULL
,	NULL
monoclonal	NULL
anti-	NULL
(	NULL
Ca**-ATPase	NULL
)	NULL
antibody	NULL
raised	NULL
using	NULL
highly	NULL
purified	NULL
platelet	NULL
intracellular	NULL
membranes	NULL
as	NULL
immunogen	NULL
.	NULL

§	NULL
To	NULL
whom	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

470	NULL
C.	NULL
Magnier	NULL
and	NULL
others	NULL
artefactual	NULL
and	NULL
due	NULL
rather	NULL
to	NULL
phosphate	NULL
contamination	NULL
of	NULL
the	NULL
commercial	NULL
C.	NULL
Sub	NULL
.	NULL

solution	NULL
than	NULL
to	NULL
the	NULL
concomitant	NULL
C.	NULL
Sub.-induced	NULL
phosphorylation	NULL
of	NULL
a	NULL
22	NULL
kDa	NULL
protein	NULL
by	NULL
itself	NULL
[	NULL
19,20	NULL
]	NULL
.	NULL

Finally	NULL
,	NULL
this	NULL
relationship	NULL
between	NULL
intracellular	NULL
cyclic	NULL
AMP	NULL
and	NULL
Ca**	NULL
uptake	NULL
was	NULL
investigated	NULL
by	NULL
using	NULL
a	NULL
kinetic	NULL
study	NULL
in	NULL
situ	NULL
,	NULL
ie	NULL
.	NULL

again	NULL
in	NULL
intact	NULL
platelets	NULL
,	NULL
which	NULL
shows	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
rate	NULL
and	NULL
maximal	NULL
extent	NULL
of	NULL
Ca**	NULL
uptake	NULL
[	NULL
21	NULL
]	NULL
.	NULL

The	NULL
aim	NULL
of	NULL
the	NULL
present	NULL
work	NULL
was	NULL
to	NULL
revisit	NULL
this	NULL
relationship	NULL
between	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
Rapl	NULL
protein	NULL
and	NULL
the	NULL
regulation	NULL
of	NULL
platelet	NULL
Ca**	NULL
transport	NULL
by	NULL
using	NULL
an	NULL
approach	NULL
distinct	NULL
from	NULL
those	NULL
previously	NULL
used	NULL
and	NULL
taking	NULL
advantage	NULL
of	NULL
the	NULL
congestive	NULL
heart	NULL
failure	NULL
model	NULL
.	NULL

Indeed	NULL
,	NULL
because	NULL
of	NULL
the	NULL
evidence	NULL
for	NULL
a	NULL
down-regulation	NULL
of	NULL
myocardial	NULL
#	NULL
-adrenoreceptors	NULL
in	NULL
this	NULL
pathology	NULL
[	NULL
22	NULL
]	NULL
,	NULL
as	NULL
well	NULL
as	NULL
altered	NULL
platelet	NULL
«	NULL
2-adrenoreceptors	NULL
in	NULL
patients	NULL
with	NULL
angina	NULL
pectoris	NULL
[	NULL
23	NULL
]	NULL
,	NULL
the	NULL
regulation	NULL
of	NULL
cyclic	NULL
AMP-phosphoproteins	NULL
such	NULL
as	NULL
the	NULL
major	NULL
Rap1B	NULL
protein	NULL
in	NULL
platelets	NULL
could	NULL
be	NULL
modified	NULL
in	NULL
heart	NULL
failure	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
we	NULL
looked	NULL
for	NULL
both	NULL
Rapl	NULL
protein	NULL
expression	NULL
and	NULL
phosphorylation	NULL
in	NULL
mixed	NULL
platelet	NULL
membranes	NULL
isolated	NULL
from	NULL
several	NULL
patients	NULL
with	NULL
heart	NULL
failure	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
detection	NULL
of	NULL
variable	NULL
abnormalities	NULL
of	NULL
the	NULL
Rapl	NULL
protein	NULL
without	NULL
significant	NULL
modification	NULL
of	NULL
the	NULL
PL/IM	NULL
430-recognizable	NULL
97	NULL
kDa	NULL
Ca*-ATPase	NULL
expression	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
further	NULL
investigate	NULL
the	NULL
relationship	NULL
between	NULL
the	NULL
Rapl	NULL
protein	NULL
and	NULL
the	NULL
regulation	NULL
of	NULL
platelet	NULL
Ca®*	NULL
uptake	NULL
using	NULL
this	NULL
pathological	NULL
model	NULL
.	NULL

By	NULL
studying	NULL
patients	NULL
with	NULL
variable	NULL
decreases	NULL
in	NULL
Rapl	NULL
protein	NULL
expression	NULL
,	NULL
a	NULL
correlation	NULL
between	NULL
its	NULL
phosphorylation	NULL
and	NULL
its	NULL
effect	NULL
on	NULL
Ca**	NULL
transport	NULL
was	NULL
found	NULL
,	NULL
thus	NULL
again	NULL
strongly	NULL
arguing	NULL
for	NULL
an	NULL
effect	NULL
of	NULL
Rapl	NULL
protein	NULL
phosphorylation	NULL
on	NULL
platelet	NULL
Ca®*	NULL
transport	NULL
.	NULL

EXPERIMENTAL	NULL
Materials	NULL
BSA	NULL
,	NULL
Hepes	NULL
,	NULL
ATP	NULL
(	NULL
sodium	NULL
salt	NULL
)	NULL
,	NULL
the	NULL
catalytic	NULL
subunit	NULL
of	NULL
the	NULL
cyclic	NULL
AMP-dependent	NULL
protein	NULL
kinase	NULL
from	NULL
bovine	NULL
heart	NULL
and	NULL
the	NULL
anti-	NULL
(	NULL
mouse	NULL
IgG	NULL
)	NULL
-horseradish	NULL
peroxidase	NULL
conjugate	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
,	NULL
U.S.A.	NULL
)	NULL
.	NULL

Products	NULL
for	NULL
electrophoresis	NULL
(	NULL
glycine	NULL
,	NULL
Tris	NULL
,	NULL
SDS	NULL
,	NULL
acrylamide	NULL
,	NULL
bisacrylamide	NULL
,	NULL
ammonium	NULL
persulphate	NULL
,	NULL
#	NULL
-mercaptoethanol	NULL
and	NULL
Temed	NULL
)	NULL
were	NULL
from	NULL
Bio-Rad	NULL
(	NULL
Richmond	NULL
,	NULL
CA	NULL
,	NULL
U.S.A.	NULL
)	NULL
.	NULL

CaCl	NULL
,	NULL
,	NULL
[	NULL
y-*°P	NULL
]	NULL
JATP	NULL
and	NULL
Enhanced	NULL
Chemiluminescence	NULL
(	NULL
ECL	NULL
)	NULL
Western	NULL
blotting	NULL
reagents	NULL
were	NULL
purchased	NULL
from	NULL
the	NULL
Radiochemical	NULL
Centre	NULL
(	NULL
Amersham	NULL
,	NULL
U.K.	NULL
)	NULL
.	NULL

Platelet	NULL
isolation	NULL
Human	NULL
blood	NULL
was	NULL
obtained	NULL
from	NULL
normal	NULL
healthy	NULL
adult	NULL
individuals	NULL
and	NULL
from	NULL
patients	NULL
with	NULL
severe	NULL
congestive	NULL
heart	NULL
failure	NULL
due	NULL
to	NULL
ischaemic	NULL
,	NULL
dilated	NULL
or	NULL
hypertrophic	NULL
cardiomyopathy	NULL
(	NULL
class	NULL
III	NULL
according	NULL
to	NULL
the	NULL
functional	NULL
classification	NULL
of	NULL
the	NULL
New	NULL
York	NULL
Heart	NULL
Association	NULL
)	NULL
.	NULL

The	NULL
investigation	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
Declaration	NULL
of	NULL
Helsinki	NULL
,	NULL
and	NULL
informed	NULL
consent	NULL
was	NULL
obtained	NULL
from	NULL
patients	NULL
and	NULL
volunteers	NULL
.	NULL

Nine	NULL
parts	NULL
of	NULL
blood	NULL
were	NULL
collected	NULL
with	NULL
one	NULL
part	NULL
of	NULL
the	NULL
ACD-C	NULL
anticoagulant	NULL
made	NULL
of	NULL
130	NULL
mM	NULL
trisodium	NULL
citrate	NULL
,	NULL
111	NULL
mM	NULL
glucose	NULL
and	NULL
152	NULL
mM	NULL
citric	NULL
acid	NULL
.	NULL

The	NULL
blood	NULL
was	NULL
centrifuged	NULL
at	NULL
120	NULL
g	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
to	NULL
obtain	NULL
platelet-rich	NULL
plasma	NULL
.	NULL

Platelets	NULL
were	NULL
then	NULL
washed	NULL
using	NULL
a	NULL
modified	NULL
Tyrode	NULL
's	NULL
buffer	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
containing	NULL
130	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
NaH	NULL
,	NULL
PO	NULL
,	NULL
,	NULL
24	NULL
mM	NULL
NaHCO	NULL
,	NULL
,	NULL
2	NULL
mM	NULL
EDTA-Na	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
glucose	NULL
,	NULL
12.5	NULL
mM	NULL
saccharose	NULL
and	NULL
0.35	NULL
%	NULL
BSA	NULL
.	NULL

Preparation	NULL
of	NULL
platelet	NULL
membranes	NULL
Platelet	NULL
membrane	NULL
vesicles	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
[	NULL
24	NULL
]	NULL
.	NULL

Briefly	NULL
,	NULL
platelets	NULL
were	NULL
disrupted	NULL
by	NULL
controlled	NULL
ultra	NULL
sonication	NULL
in	NULL
a	NULL
lysis	NULL
buffer	NULL
containing	NULL
25	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7	NULL
,	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
2	NULL
mM	NULL
MgSO	NULL
,	NULL
,	NULL
25	NULL
mM	NULL
NaCl	NULL
,	NULL
12	NULL
mM	NULL
sodium	NULL
citrate	NULL
,	NULL
10	NULL
mM	NULL
glucose	NULL
,	NULL
5	NULL
mM	NULL
ATP	NULL
,	NULL
0.35	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
BSA	NULL
,	NULL
0.8	NULL
mg	NULL
of	NULL
/m	NULL
!	NULL

and	NULL
0.1	NULL
unit	NULL
of	NULL
aprotinin/ml	NULL
.	NULL

Lysed	NULL
platelets	NULL
were	NULL
centrifuged	NULL
at	NULL
19000g	NULL
to	NULL
eliminate	NULL
unlysed	NULL
platelets	NULL
,	NULL
mitochondria	NULL
and	NULL
granules	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
centrifuged	NULL
at	NULL
100000	NULL
g	NULL
and	NULL
the	NULL
pellet	NULL
was	NULL
used	NULL
as	NULL
the	NULL
source	NULL
of	NULL
membrane	NULL
vesicles	NULL
.	NULL

This	NULL
100000	NULL
g	NULL
mixed	NULL
membrane	NULL
fraction	NULL
has	NULL
been	NULL
fully	NULL
characterized	NULL
and	NULL
consists	NULL
of	NULL
a	NULL
mixture	NULL
of	NULL
plasma	NULL
and	NULL
intracellular	NULL
membranes	NULL
[	NULL
25	NULL
]	NULL
.	NULL

The	NULL
protein	NULL
content	NULL
of	NULL
the	NULL
membrane	NULL
fractions	NULL
was	NULL
measured	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Bradford	NULL
using	NULL
y-globulins	NULL
as	NULL
standard	NULL
[	NULL
26	NULL
]	NULL
.	NULL

SDS/PAGE	NULL
Aliquots	NULL
of	NULL
membrane	NULL
fractions	NULL
were	NULL
solubilized	NULL
in	NULL
the	NULL
following	NULL
buffer	NULL
:	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
6	NULL
.	NULL

8	NULL
,	NULL
containing	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
0.01	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
Bromophenol	NULL
Blue	NULL
and	NULL
25	NULL
%	NULL
glycerol	NULL
.	NULL

Samples	NULL
were	NULL
treated	NULL
for	NULL
reduction	NULL
for	NULL
15	NULL
min	NULL
at	NULL
60°C	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
5	NULL
%	NULL
/-mercaptoethanol	NULL
and	NULL
applied	NULL
to	NULL
SDS/11	NULL
or	NULL
1	NULL
5	NULL
%	NULL
-polyacrylamide	NULL
slab	NULL
gels	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Laemmli	NULL
[	NULL
27	NULL
]	NULL
.	NULL

Electrophoresis	NULL
was	NULL
performed	NULL
at	NULL
40	NULL
V	NULL
overnight	NULL
.	NULL

Cyclic	NULL
AMP-induced	NULL
Rap1	NULL
protein	NULL
phosphorylation	NULL
Incubations	NULL
were	NULL
conducted	NULL
at	NULL
30	NULL
°C	NULL
for	NULL
10	NULL
min	NULL
in	NULL
a	NULL
reaction	NULL
mixture	NULL
containing	NULL
10	NULL
mM	NULL
sodium	NULL
phosphate	NULL
buffer	NULL
,	NULL
pH	NULL
7.0	NULL
,	NULL
15	NULL
mM	NULL
MgSO	NULL
,	NULL
,	NULL
100	NULL
mM	NULL
NaF	NULL
,	NULL
6	NULL
mM	NULL
[	NULL
y-*°P	NULL
]	NULL
JATP	NULL
(	NULL
460	NULL
MBq/	NULL
mmol	NULL
)	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
catalytic	NULL
subunit	NULL
of	NULL
the	NULL
cyclic	NULL
AMP-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
enzyme	NULL
=	NULL
0.02	NULL
)	NULL
[	NULL
28	NULL
]	NULL
.	NULL

Reactions	NULL
were	NULL
initiated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
[	NULL
y-**P	NULL
]	NULL
ATP	NULL
and	NULL
stopped	NULL
by	NULL
adding	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
solubilization	NULL
buffer	NULL
containing	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
6.8	NULL
,	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
0.01	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
Bromophenol	NULL
Blue	NULL
and	NULL
25	NULL
%	NULL
glycerol	NULL
.	NULL

Membrane	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS/PAGE	NULL
as	NULL
described	NULL
above	NULL
.	NULL

They	NULL
were	NULL
electrotransferred	NULL
on	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
for	NULL
2	NULL
h	NULL
at	NULL
250	NULL
mA	NULL
and	NULL
4°C	NULL
and	NULL
autoradiographed	NULL
at	NULL
-	NULL
80	NULL
°C	NULL
using	NULL
Kodak	NULL
X-Omat	NULL
AR	NULL
films	NULL
and	NULL
intensifying	NULL
screens	NULL
.	NULL

Western	NULL
blot	NULL
procedure	NULL
(	NULL
a	NULL
)	NULL
The	NULL
anti-Rapl	NULL
polyclonal	NULL
rabbit	NULL
antibody	NULL
was	NULL
raised	NULL
against	NULL
a	NULL
peptide	NULL
encompassing	NULL
residues	NULL
121-137	NULL
of	NULL
the	NULL
Rapl	NULL
proteins	NULL
.	NULL

Its	NULL
preparation	NULL
and	NULL
characterization	NULL
are	NULL
described	NULL
in	NULL
detail	NULL
elsewhere	NULL
[	NULL
29,30	NULL
]	NULL
.	NULL

This	NULL
antibody	NULL
recognizes	NULL
both	NULL
RaplA	NULL
and	NULL
Rap1B	NULL
proteins	NULL
.	NULL

Nitrocellulose	NULL
membranes	NULL
were	NULL
blocked	NULL
in	NULL
TBS	NULL
(	NULL
10	NULL
mM	NULL
Tris/HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
)	NULL
containing	NULL
5	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
non-fat	NULL
dry	NULL
milk	NULL
,	NULL
at	NULL
37°C	NULL
for	NULL
1	NULL
h	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
a	NULL
1	NULL
:	NULL
100	NULL
dilution	NULL
of	NULL
anti-Rapl	NULL
serum	NULL
in	NULL
TBS	NULL
containing	NULL
0.5	NULL
%	NULL
nonfat	NULL
dry	NULL
milk	NULL
for	NULL
2	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
this	NULL
step	NULL
,	NULL
the	NULL
nitrocellulose	NULL
membranes	NULL
were	NULL
washed	NULL
five	NULL
times	NULL
with	NULL
distilled	NULL
water	NULL
and	NULL
then	NULL
with	NULL
TBS	NULL
and	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Antibody	NULL
binding	NULL
was	NULL
revealed	NULL
by	NULL
1	NULL
h	NULL
of	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
of	NULL
the	NULL
nitrocellulose	NULL
membranes	NULL
with	NULL
1850	NULL
MBq/m	NULL
!	NULL

'*	NULL
``	NULL
I-labelled	NULL
Protein	NULL
A	NULL
(	NULL
30000	NULL
c.p.m./strip	NULL
)	NULL
in	NULL
TBS	NULL
and	NULL
0.5	NULL
%	NULL
non-fat	NULL
dry	NULL
milk	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
then	NULL
washed	NULL
twice	NULL
in	NULL
TBS	NULL
and	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
.	NULL

Autoradiography	NULL
of	NULL
the	NULL
dried	NULL
nitrocellulose	NULL
membranes	NULL
was	NULL
performed	NULL
at	NULL
-80	NULL
°C	NULL
using	NULL
Kodak	NULL
X-Omat	NULL
AR	NULL
films	NULL
and	NULL
intensifying	NULL
screens	NULL
.	NULL

(	NULL
b	NULL
)	NULL
The	NULL
monoclonal	NULL
PL/IM	NULL
430	NULL
antibody	NULL
was	NULL
raised	NULL
using	NULL
highly	NULL
purified	NULL
platelet	NULL
intracellular	NULL
membrane	NULL
vesicles	NULL
as	NULL
immunogen	NULL
,	NULL
and	NULL
purified	NULL
from	NULL
culture	NULL
supernatant	NULL
of	NULL
the	NULL
corresponding	NULL
hybridoma	NULL
cell	NULL
line	NULL
by	NULL
Protein	NULL
A	NULL
affinity	NULL
chromato-graphy	NULL
at	NULL
high	NULL
ionic	NULL
strength	NULL
(	NULL
3	NULL
M	NULL
NaCl	NULL
)	NULL
[	NULL
8	NULL
]	NULL
.	NULL

Its	NULL
preparation	NULL
and	NULL
characterization	NULL
are	NULL
described	NULL
elsewhere	NULL
[	NULL
31	NULL
]	NULL
.	NULL

Briefly	NULL
,	NULL
this	NULL
antibody	NULL
inhibits	NULL
Ca**	NULL
uptake	NULL
into	NULL
platelet	NULL
membrane	NULL
vesicles	NULL
and	NULL
Rap1	NULL
protein	NULL
and	NULL
Ca	NULL
#	NULL
+*	NULL
fluxes	NULL
in	NULL
platelets	NULL
471	NULL
Ca®*	NULL
sequestration	NULL
into	NULL
intracellular	NULL
stores	NULL
in	NULL
saponin-per-meabilized	NULL
platelets	NULL
,	NULL
and	NULL
specifically	NULL
recognizes	NULL
the	NULL
97	NULL
kDa	NULL
Ca**-ATPase	NULL
in	NULL
platelets	NULL
and	NULL
different	NULL
cell	NULL
lines	NULL
(	NULL
32	NULL
]	NULL
.	NULL

Nitrocellulose	NULL
membranes	NULL
were	NULL
treated	NULL
overnight	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
a	NULL
quenching	NULL
solution	NULL
containing	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
mM	NULL
Tris/HCl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
and	NULL
5	NULL
%	NULL
non-fat	NULL
dry	NULL
milk	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
then	NULL
rinsed	NULL
with	NULL
the	NULL
same	NULL
solution	NULL
and	NULL
incubated	NULL
with	NULL
the	NULL
purified	NULL
PL/IM	NULL
430	NULL
antibody	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
1	NULL
ug/ml	NULL
for	NULL
2	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

There-after	NULL
,	NULL
the	NULL
nitrocellulose	NULL
sheets	NULL
were	NULL
extensively	NULL
washed	NULL
with	NULL
the	NULL
quenching	NULL
solution	NULL
and	NULL
further	NULL
incubated	NULL
with	NULL
the	NULL
anti-	NULL
(	NULL
mouse	NULL
IgG	NULL
)	NULL
-horseradish	NULL
peroxidase	NULL
conjugate	NULL
(	NULL
1	NULL
:	NULL
2000	NULL
dilution	NULL
)	NULL
for	NULL
2	NULL
h.	NULL
After	NULL
washing	NULL
steps	NULL
,	NULL
antibody	NULL
binding	NULL
was	NULL
detected	NULL
by	NULL
using	NULL
the	NULL
ECL	NULL
Western	NULL
blotting	NULL
reagents	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
manufacturer	NULL
.	NULL

Measurement	NULL
of	NULL
Ca*+	NULL
uptake	NULL
into	NULL
platelet	NULL
membrane	NULL
vesicles	NULL
Calcium	NULL
uptake	NULL
by	NULL
the	NULL
membrane	NULL
vesicles	NULL
was	NULL
measured	NULL
by	NULL
incubating	NULL
100	NULL
ug	NULL
of	NULL
platelet	NULL
membranes	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
reaction	NULL
mixture	NULL
containing	NULL
20	NULL
mM	NULL
Hepes	NULL
buffer	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
5	NULL
or	NULL
10	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mM	NULL
*CaCl	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
EGTA	NULL
.	NULL

The	NULL
final	NULL
concentration	NULL
of	NULL
free	NULL
Ca**	NULL
was	NULL
1.6	NULL
M	NULL
as	NULL
calculated	NULL
according	NULL
to	NULL
Fabiato	NULL
and	NULL
Fabiato	NULL
[	NULL
33	NULL
]	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
started	NULL
by	NULL
adding	NULL
5	NULL
mM	NULL
ATP	NULL
to	NULL
the	NULL
incubation	NULL
medium	NULL
and	NULL
stirring	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

At	NULL
various	NULL
intervals	NULL
,	NULL
0.1	NULL
ml	NULL
aliquots	NULL
were	NULL
withdrawn	NULL
and	NULL
filtered	NULL
through	NULL
Millipore	NULL
filters	NULL
(	NULL
HAWP	NULL
0.45-um	NULL
pore	NULL
size	NULL
)	NULL
previously	NULL
soaked	NULL
in	NULL
a	NULL
2	NULL
mg/ml	NULL
BSA	NULL
solution	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
5	NULL
ml	NULL
of	NULL
0.1	NULL
M	NULL
CaCl	NULL
,	NULL
and	NULL
counted	NULL
for	NULL
radioactivity	NULL
in	NULL
10	NULL
ml	NULL
of	NULL
scintillation	NULL
liquid	NULL
.	NULL

RESULTS	NULL
Relationship	NULL
between	NULL
platelet	NULL
Ca**	NULL
transport	NULL
and	NULL
Rap1	NULL
protein	NULL
phosphorylation	NULL
Effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

dialysis	NULL
We	NULL
first	NULL
carried	NULL
out	NULL
experiments	NULL
to	NULL
re-explore	NULL
the	NULL
relationship	NULL
between	NULL
Rapl	NULL
protein	NULL
phosphorylation	NULL
and	NULL
the	NULL
regulation	NULL
of	NULL
Ca**	NULL
transport	NULL
,	NULL
by	NULL
testing	NULL
different	NULL
experimental	NULL
conditions	NULL
.	NULL

Because	NULL
one	NULL
argument	NULL
for	NULL
an	NULL
effect	NULL
of	NULL
phosphate	NULL
ions	NULL
present	NULL
in	NULL
the	NULL
catalytic	NULL
subunit	NULL
of	NULL
the	NULL
cyclic	NULL
AMP-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
C	NULL
.	NULL

Sub	NULL
.	NULL
)	NULL

over	NULL
that	NULL
of	NULL
concomitant	NULL
C.	NULL
Sub.-induced	NULL
protein	NULL
phosphorylation	NULL
on	NULL
Ca**	NULL
uptake	NULL
was	NULL
based	NULL
on	NULL
the	NULL
fact	NULL
that	NULL
dialysed	NULL
C.	NULL
Sub	NULL
.	NULL

was	NULL
inactive	NULL
(	NULL
whereas	NULL
it	NULL
fully	NULL
phosphorylated	NULL
a	NULL
22	NULL
kDa	NULL
protein	NULL
[	NULL
20	NULL
]	NULL
)	NULL
,	NULL
we	NULL
proceeded	NULL
with	NULL
dialysis	NULL
of	NULL
the	NULL
C.	NULL
Sub	NULL
.	NULL

preparation	NULL
.	NULL

Then	NULL
,	NULL
we	NULL
tested	NULL
its	NULL
effect	NULL
on	NULL
isolated	NULL
platelet	NULL
membranes	NULL
for	NULL
specific	NULL
Rapl	NULL
protein	NULL
phosphorylation	NULL
as	NULL
previously	NULL
characterized	NULL
[	NULL
16,18	NULL
]	NULL
(	NULL
Figure	NULL
1a	NULL
)	NULL
and	NULL
Ca®*	NULL
uptake	NULL
under	NULL
conditions	NULL
again	NULL
previously	NULL
used	NULL
and	NULL
characterized	NULL
as	NULL
allowing	NULL
total	NULL
Ca®*	NULL
uptake	NULL
mediated	NULL
by	NULL
the	NULL
multi-SERCA	NULL
system	NULL
{	NULL
24,25,34,35	NULL
]	NULL
(	NULL
Figure	NULL
1b	NULL
)	NULL
.	NULL

Figure	NULL
1	NULL
(	NULL
a	NULL
)	NULL
shows	NULL
that	NULL
we	NULL
did	NULL
not	NULL
succeed	NULL
in	NULL
maintaining	NULL
a	NULL
full	NULL
C.	NULL
Sub	NULL
.	NULL

activity	NULL
to	NULL
phosphorylate	NULL
the	NULL
Rapl	NULL
protein	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
comparison	NULL
between	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
obviously	NULL
shows	NULL
significant	NULL
reduction	NULL
in	NULL
phosphorylation	NULL
of	NULL
the	NULL
Rapl	NULL
protein	NULL
after	NULL
dialysis	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
this	NULL
finding	NULL
was	NULL
the	NULL
result	NULL
of	NULL
Figure	NULL
1	NULL
(	NULL
b	NULL
)	NULL
showing	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
significant	NULL
effect	NULL
of	NULL
dialysed	NULL
C.	NULL
Sub	NULL
.	NULL

on	NULL
total	NULL
Ca**	NULL
uptake	NULL
,	NULL
whereas	NULL
non-dialysed	NULL
C.	NULL
Sub	NULL
.	NULL

induced	NULL
the	NULL
twofold	NULL
stimulation	NULL
previously	NULL
observed	NULL
.	NULL

So	NULL
,	NULL
these	NULL
findings	NULL
mean	NULL
that	NULL
,	NULL
in	NULL
our	NULL
hands	NULL
,	NULL
the	NULL
dissociation	NULL
between	NULL
the	NULL
effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

and	NULL
that	NULL
of	NULL
phosphate	NULL
on	NULL
Ca**	NULL
uptake	NULL
can	NULL
not	NULL
be	NULL
obtained	NULL
using	NULL
dialysed	NULL
C.	NULL
Sub	NULL
.	NULL

Consequently	NULL
,	NULL
we	NULL
were	NULL
led	NULL
to	NULL
develop	NULL
the	NULL
following	NULL
approaches	NULL
.	NULL

(	NULL
a	NULL
)	NULL
24	NULL
kDa	NULL
-	NULL
»	NULL
as	NULL
«	NULL
wiih	NULL
1	NULL
2	NULL
3	NULL
100	NULL
-	NULL
(	NULL
b	NULL
)	NULL
S	NULL
0	NULL
re	NULL
§	NULL
50-4	NULL
3	NULL
NO	NULL
o	NULL
0	NULL
-	NULL
A	NULL
0	NULL
10	NULL
20	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
Figure	NULL
1	NULL
-	NULL
Relationship	NULL
between	NULL
platelet	NULL
Rap1	NULL
protein	NULL
phosphorylation	NULL
(	NULL
a	NULL
)	NULL
and	NULL
Ca*+	NULL
transport	NULL
(	NULL
b	NULL
)	NULL
(	NULL
a	NULL
)	NULL
Effect	NULL
of	NULL
dialysis	NULL
on	NULL
C.	NULL
Sub.-induced	NULL
Rap1	NULL
protein	NULL
phosphorylation	NULL
.	NULL

Mixed	NULL
platelet	NULL
membranes	NULL
were	NULL
isolated	NULL
from	NULL
fresh	NULL
platelets	NULL
after	NULL
lysis	NULL
and	NULL
differential	NULL
centrifugation	NULL
at	NULL
19000	NULL
g	NULL
and	NULL
100.000	NULL
g	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Experimental	NULL
section	NULL
.	NULL

Membrane	NULL
proteins	NULL
(	NULL
50	NULL
g	NULL
)	NULL
were	NULL
phosphorylated	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
15	NULL
of	NULL
catalytic	NULL
subunit	NULL
of	NULL
the	NULL
cyclic	NULL
AMP-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
C	NULL
.	NULL

Sub	NULL
.	NULL
)	NULL

,	NULL
either	NULL
directly	NULL
or	NULL
after	NULL
dialysis	NULL
.	NULL

Dialysis	NULL
was	NULL
performed	NULL
at	NULL
4	NULL
°C	NULL
using	NULL
Millipore	NULL
filter	NULL
VSWP	NULL
(	NULL
0.025	NULL
«	NULL
m	NULL
pore	NULL
size	NULL
)	NULL
for	NULL
2	NULL
h	NULL
in	NULL
25	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
8	NULL
,	NULL
100	NULL
mM	NULL
KCI	NULL
.	NULL

Reactions	NULL
were	NULL
stopped	NULL
,	NULL
and	NULL
samples	NULL
were	NULL
reduced	NULL
using	NULL
5	NULL
%	NULL
/	NULL
#	NULL
-mercaptho-ethanol	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
on	NULL
SDS/11	NULL
%	NULL
-PAGE	NULL
,	NULL
electrotransferred	NULL
and	NULL
submitted	NULL
to	NULL
auto-radiography	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
phosphorylation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
C	NULL
.	NULL

Sub	NULL
.	NULL

;	NULL
lane	NULL
2	NULL
,	NULL
dialysed	NULL
C.	NULL
Sub.-induced	NULL
Rap1	NULL
protein	NULL
phosphorylation	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
control	NULL
C.	NULL
Sub.-induced	NULL
Rap1	NULL
protein	NULL
phosphorylation	NULL
.	NULL

The	NULL
Figure	NULL
is	NULL
typical	NULL
of	NULL
two	NULL
experiments	NULL
.	NULL

(	NULL
)	NULL
Effect	NULL
of	NULL
dialysed	NULL
C.	NULL
Sub	NULL
.	NULL

on	NULL
Ca	NULL
#	NULL
*	NULL
uptake	NULL
into	NULL
membrane	NULL
vesicles	NULL
.	NULL

Mixed	NULL
platelet	NULL
membranes	NULL
(	NULL
100000	NULL
g	NULL
pellet	NULL
)	NULL
were	NULL
isolated	NULL
from	NULL
normal	NULL
individuals	NULL
.	NULL

They	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
reaction	NULL
mixture	NULL
containing	NULL
20	NULL
mM	NULL
Hepes	NULL
buffer	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mM	NULL
*	NULL
``	NULL
CaCl	NULL
;	NULL
and	NULL
0.5	NULL
mM	NULL
EGTA	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
15	NULL
g/m	NULL
!	NULL

of	NULL
C.	NULL
Sub	NULL
.	NULL

used	NULL
either	NULL
before	NULL
or	NULL
after	NULL
dialysis	NULL
.	NULL

Ca+	NULL
uptake	NULL
was	NULL
started	NULL
by	NULL
adding	NULL
5	NULL
mM	NULL
ATP	NULL
to	NULL
the	NULL
incubation	NULL
medium	NULL
and	NULL
stirring	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Aliquots	NULL
were	NULL
withdrawn	NULL
at	NULL
the	NULL
times	NULL
indicated	NULL
and	NULL
membrane	NULL
vesicles	NULL
were	NULL
treated	NULL
for	NULL
Ca*	NULL
uptake	NULL
measurements	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Experimental	NULL
section	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
percentages	NULL
of	NULL
maximal	NULL
Ca*+*	NULL
uptake	NULL
in	NULL
membrane	NULL
vesicles	NULL
measured	NULL
at	NULL
15	NULL
min	NULL
and	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
non-dialysed	NULL
C	NULL
.	NULL

Sub	NULL
.	NULL

,	NULL
arbitrarily	NULL
taken	NULL
as	NULL
100	NULL
%	NULL
.	NULL

MB	NULL
,	NULL
Ca*	NULL
uptake	NULL
into	NULL
membrane	NULL
vesicles	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
C	NULL
.	NULL

Sub	NULL
.	NULL

;	NULL
A	NULL
,	NULL
uptake	NULL
into	NULL
membrane	NULL
vesicles	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
non-dialysed	NULL
C	NULL
.	NULL

Sub	NULL
.	NULL

;	NULL
C	NULL
,	NULL
Ca	NULL
#	NULL
*	NULL
uptake	NULL
into	NULL
membrane	NULL
vesicles	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
dialysed	NULL
C.	NULL
Sub	NULL
.	NULL

The	NULL
Figure	NULL
is	NULL
typical	NULL
of	NULL
two	NULL
experiments	NULL
.	NULL

The	NULL
priming	NULL
effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

To	NULL
begin	NULL
with	NULL
,	NULL
we	NULL
tried	NULL
to	NULL
dissociate	NULL
the	NULL
effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

from	NULL
that	NULL
of	NULL
phosphate	NULL
ions	NULL
and	NULL
focused	NULL
on	NULL
the	NULL
Ca**	NULL
uptake	NULL
mediated	NULL
by	NULL
the	NULL
PL/IM	NULL
430-recognizable	NULL
SERCA	NULL
target	NULL
of	NULL
the	NULL
Rapl	NULL
protein	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
we	NULL
took	NULL
advantage	NULL
of	NULL
the	NULL
following	NULL
previous	NULL
observations	NULL
about	NULL
the	NULL
platelet	NULL
Ca®**-ATPase	NULL
system	NULL
:	NULL
(	NULL
i	NULL
)	NULL
the	NULL
PL	NULL
/IM	NULL
430-recognizable	NULL
97	NULL
kDa	NULL
Ca**-ATPase	NULL
accounts	NULL
for	NULL
a	NULL
large	NULL
part	NULL
of	NULL
Ca®**	NULL
uptake	NULL
among	NULL
the	NULL
multi-SERCA	NULL
[	NULL
36	NULL
]	NULL
and	NULL
4172	NULL
C.	NULL
Magnier	NULL
and	NULL
others	NULL
co	NULL
o	NULL
Ca**	NULL
uptake	NULL
(	NULL
nmol/mg	NULL
of	NULL
protein	NULL
)	NULL
&	NULL
/	NULL
0	NULL
I	NULL
I	NULL
I	NULL
U	NULL
o	NULL
10	NULL
20	NULL
30	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
Figure	NULL
2	NULL
-	NULL
Relationship	NULL
between	NULL
platelet	NULL
Rap1	NULL
protein	NULL
phosphorylation	NULL
and	NULL
Ca'+	NULL
uptake	NULL
:	NULL
evidence	NULL
for	NULL
Ca	NULL
``	NULL
uptake	NULL
as	NULL
a	NULL
function	NULL
of	NULL
Rap1	NULL
protein	NULL
phosphorylation	NULL
Mixed	NULL
platelet	NULL
membrane	NULL
vesicles	NULL
(	NULL
100000	NULL
g	NULL
pellet	NULL
)	NULL
were	NULL
isolated	NULL
from	NULL
four	NULL
normal	NULL
individuals	NULL
.	NULL

They	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
reaction	NULL
mixture	NULL
containing	NULL
20	NULL
mM	NULL
Hepes	NULL
buffer	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
10	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mM	NULL
``	NULL
CaCl	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
EGTA	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
15	NULL
g/m	NULL
!	NULL

of	NULL
the	NULL
C.	NULL
Sub	NULL
.	NULL

The	NULL
final	NULL
concentration	NULL
of	NULL
free	NULL
was	NULL
1.6	NULL
«	NULL
M	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
started	NULL
by	NULL
adding	NULL
5	NULL
mM	NULL
ATP	NULL
to	NULL
the	NULL
incubation	NULL
medium	NULL
and	NULL
stirring	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Aliquots	NULL
were	NULL
withdrawn	NULL
at	NULL
the	NULL
times	NULL
indicated	NULL
and	NULL
membrane	NULL
vesicles	NULL
were	NULL
treated	NULL
for	NULL
Ca	NULL
``	NULL
*	NULL
uptake	NULL
measurements	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Experimental	NULL
section	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
in	NULL
nmol/mg	NULL
of	NULL
protein	NULL
and	NULL
are	NULL
the	NULL
means	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
four	NULL
experiments	NULL
.	NULL

BBB	NULL
,	NULL
Ca	NULL
``	NULL
*	NULL
uptake	NULL
into	NULL
membrane	NULL
vesicles	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
C	NULL
.	NULL

Sub	NULL
.	NULL

;	NULL
C	NULL
]	NULL
,	NULL
Ca**	NULL
uptake	NULL
into	NULL
membrane	NULL
vesicles	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

requires	NULL
higher	NULL
ATP	NULL
concentrations	NULL
than	NULL
the	NULL
SERCA	NULL
2-b	NULL
and	NULL
SERCA	NULL
3	NULL
isoforms	NULL
[	NULL
8	NULL
]	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
Mg**-ATPase	NULL
activities	NULL
are	NULL
present	NULL
in	NULL
mixed	NULL
membrane	NULL
fractions	NULL
which	NULL
can	NULL
mask	NULL
the	NULL
SERCA	NULL
activities	NULL
[	NULL
34	NULL
]	NULL
.	NULL

So	NULL
,	NULL
we	NULL
postulated	NULL
that	NULL
this	NULL
masking	NULL
of	NULL
Ca**	NULL
uptake	NULL
by	NULL
increasing	NULL
MgCl	NULL
,	NULL
should	NULL
be	NULL
particularly	NULL
effective	NULL
as	NULL
regards	NULL
the	NULL
PL	NULL
/IM	NULL
430-recognizable	NULL
97	NULL
kDa	NULL
Ca**-ATPase	NULL
.	NULL

In	NULL
such	NULL
a	NULL
case	NULL
,	NULL
it	NULL
should	NULL
be	NULL
possible	NULL
to	NULL
look	NULL
for	NULL
some	NULL
priming	NULL
role	NULL
of	NULL
the	NULL
Rapl	NULL
protein	NULL
phosphorylation	NULL
to	NULL
induce	NULL
Ca®*	NULL
uptake	NULL
,	NULL
thus	NULL
allowing	NULL
the	NULL
subsequent	NULL
effect	NULL
of	NULL
phosphate	NULL
ions	NULL
on	NULL
the	NULL
Ca**	NULL
transport	NULL
,	NULL
ie	NULL
.	NULL

dissociating	NULL
the	NULL
two	NULL
effects	NULL
in	NULL
a	NULL
sequential	NULL
manner	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
isolated	NULL
mixed	NULL
platelet	NULL
membrane	NULL
fractions	NULL
and	NULL
tested	NULL
the	NULL
effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

on	NULL
Ca**	NULL
uptake	NULL
under	NULL
the	NULL
experimental	NULL
conditions	NULL
of	NULL
Figure	NULL
1	NULL
(	NULL
b	NULL
)	NULL
,	NULL
except	NULL
for	NULL
MgCl	NULL
,	NULL
concentration	NULL
,	NULL
which	NULL
was	NULL
increased	NULL
by	NULL
a	NULL
factor	NULL
of	NULL
two	NULL
.	NULL

Figure	NULL
2	NULL
shows	NULL
the	NULL
results	NULL
of	NULL
these	NULL
experiments	NULL
conducted	NULL
on	NULL
platelet	NULL
membrane	NULL
vesicles	NULL
isolated	NULL
from	NULL
normal	NULL
individuals	NULL
.	NULL

Whereas	NULL
the	NULL
Ca**	NULL
uptake	NULL
was	NULL
very	NULL
low	NULL
under	NULL
these	NULL
conditions	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
the	NULL
time	NULL
course	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

was	NULL
strikingly	NULL
different	NULL
.	NULL

(	NULL
i	NULL
)	NULL
It	NULL
appeared	NULL
to	NULL
be	NULL
delayed	NULL
in	NULL
comparison	NULL
with	NULL
our	NULL
previous	NULL
findings	NULL
(	NULL
Figure	NULL
1b	NULL
)	NULL
,	NULL
i.e	NULL
.	NULL

not	NULL
observed	NULL
in	NULL
the	NULL
first	NULL
minutes	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
and	NULL
very	NULL
interestingly	NULL
,	NULL
the	NULL
stimulation	NULL
of	NULL
Ca®*	NULL
uptake	NULL
began	NULL
to	NULL
be	NULL
visualizable	NULL
clearly	NULL
after	NULL
10	NULL
min	NULL
in-cubation	NULL
,	NULL
the	NULL
corresponding	NULL
time	NULL
for	NULL
a	NULL
maximal	NULL
effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

on	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
Rapl	NULL
protein	NULL
[	NULL
35-37	NULL
]	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
It	NULL
was	NULL
much	NULL
more	NULL
pronounced	NULL
,	NULL
as	NULL
it	NULL
increased	NULL
by	NULL
a	NULL
factor	NULL
of	NULL
about	NULL
8	NULL
,	NULL
reaching	NULL
a	NULL
Ca®*	NULL
uptake	NULL
of	NULL
80	NULL
nmol/mg	NULL
of	NULL
protein	NULL
at	NULL
30	NULL
min	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
specific	NULL
unmasking	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

on	NULL
its	NULL
target	NULL
Ca®	NULL
``	NULL
*-ATPase	NULL
.	NULL

So	NULL
,	NULL
the	NULL
most	NULL
likely	NULL
interpretation	NULL
for	NULL
these	NULL
results	NULL
is	NULL
that	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
Rapl	NULL
protein	NULL
induced	NULL
by	NULL
C.	NULL
Sub	NULL
.	NULL

appears	NULL
as	NULL
a	NULL
condition	NULL
for	NULL
platelet	NULL
Ca**	NULL
transport	NULL
and	NULL
occurs	NULL
prior	NULL
to	NULL
the	NULL
effect	NULL
of	NULL
phosphate	NULL
ions	NULL
,	NULL
thus	NULL
constituting	NULL
new	NULL
experimental	NULL
conditions	NULL
under	NULL
which	NULL
to	NULL
study	NULL
the	NULL
relationship	NULL
between	NULL
Rapl	NULL
protein	NULL
phosphorylation	NULL
and	NULL
the	NULL
regulation	NULL
of	NULL
Ca**	NULL
transport	NULL
.	NULL

(	NULL
a	NULL
)	NULL
(	NULL
b	NULL
)	NULL
97	NULL
kDa	NULL
--	NULL
w.	NULL
sine	NULL
ome	NULL
-	NULL
%	NULL
-	NULL
$	NULL
-	NULL
$	NULL
-	NULL
+	NULL
w=	NULL
«	NULL
»	NULL
«	NULL
\	NULL
--	NULL
24	NULL
kDa	NULL
C	NULL
1	NULL
2	NULL
3	NULL
C	NULL
1	NULL
2	NULL
3	NULL
Figure	NULL
3	NULL
-	NULL
Expression	NULL
of	NULL
PL/IM	NULL
430-recognizable	NULL
97	NULL
kDa	NULL
Ca®+*-ATPase	NULL
and	NULL
Rap1	NULL
protein	NULL
phosphorylation	NULL
in	NULL
platelet	NULL
membranes	NULL
isolated	NULL
from	NULL
a	NULL
normal	NULL
Individual	NULL
or	NULL
from	NULL
patients	NULL
with	NULL
heart	NULL
failure	NULL
Mixed	NULL
platelet	NULL
membrane	NULL
proteins	NULL
were	NULL
isolated	NULL
from	NULL
either	NULL
a	NULL
normal	NULL
individual	NULL
or	NULL
from	NULL
three	NULL
patients	NULL
with	NULL
congestive	NULL
heart	NULL
failure	NULL
.	NULL

They	NULL
were	NULL
then	NULL
either	NULL
treated	NULL
for	NULL
detection	NULL
of	NULL
the	NULL
97	NULL
kDa	NULL
platelet	NULL
Ca	NULL
@	NULL
*-ATPase	NULL
or	NULL
for	NULL
Rapt	NULL
protein	NULL
phosphorylation	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Experimental	NULL
section	NULL
.	NULL

(	NULL
@	NULL
)	NULL
Immunodetection	NULL
of	NULL
the	NULL
97	NULL
kDa	NULL
platelet	NULL
Ca+*-ATPase	NULL
;	NULL
50	NULL
q	NULL
of	NULL
platelet	NULL
membrane	NULL
proteins	NULL
were	NULL
submitted	NULL
to	NULL
SDS/15	NULL
%	NULL
-PAGE	NULL
.	NULL

Proteins	NULL
were	NULL
electrotransferred	NULL
for	NULL
2	NULL
h	NULL
at	NULL
250	NULL
mA	NULL
on	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
and	NULL
the	NULL
blots	NULL
were	NULL
treated	NULL
for	NULL
immunodetection	NULL
of	NULL
the	NULL
97	NULL
kDa	NULL
platelet	NULL
Ca	NULL
``	NULL
*-ATPase	NULL
as	NULL
follows	NULL
:	NULL
the	NULL
nitrocellulose	NULL
membranes	NULL
were	NULL
blocked	NULL
by	NULL
incubation	NULL
with	NULL
a	NULL
quenching	NULL
solution	NULL
containing	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
mM	NULL
Tris/HCl	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
and	NULL
5	NULL
%	NULL
non-fat	NULL
dry	NULL
milk	NULL
.	NULL

They	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
1	NULL
purified	NULL
PL/IM	NULL
430	NULL
monoclonal	NULL
antibody	NULL
for	NULL
2	NULL
h	NULL
and	NULL
revelation	NULL
of	NULL
antibody	NULL
binding	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
ECL	NULL
kit	NULL
.	NULL

Lane	NULL
C	NULL
,	NULL
normal	NULL
individual	NULL
platelet	NULL
membrane	NULL
proteins	NULL
;	NULL
lane	NULL
1	NULL
,	NULL
patient	NULL
1	NULL
platelet	NULL
membrane	NULL
proteins	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
patient	NULL
2	NULL
platelet	NULL
membrane	NULL
proteins	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
patient	NULL
3	NULL
platelet	NULL
membrane	NULL
proteins	NULL
.	NULL

This	NULL
Figure	NULL
is	NULL
typical	NULL
of	NULL
two	NULL
experiments	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Cyclic	NULL
AMP-induced	NULL
Rap1	NULL
protein	NULL
phosphorylation	NULL
.	NULL

Platelet	NULL
membrane	NULL
proteins	NULL
(	NULL
50	NULL
7g	NULL
)	NULL
were	NULL
phosphorylated	NULL
under	NULL
the	NULL
conditions	NULL
described	NULL
in	NULL
the	NULL
Experimental	NULL
section	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
lanes	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
lanes	NULL
-	NULL
)	NULL
of	NULL
15	NULL
pg/ml	NULL
of	NULL
the	NULL
catalytic	NULL
subunit	NULL
of	NULL
the	NULL
cyclic	NULL
AMP-dependent	NULL
protein	NULL
kinase	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
stopped	NULL
and	NULL
membrane	NULL
proteins	NULL
were	NULL
separated	NULL
on	NULL
SDS/PAGE	NULL
(	NULL
15	NULL
%	NULL
gel	NULL
)	NULL
.	NULL

They	NULL
were	NULL
electrotransferred	NULL
on	NULL
to	NULL
nitroceltulose	NULL
membranes	NULL
as	NULL
described	NULL
above	NULL
and	NULL
autoradiographed	NULL
for	NULL
2	NULL
days	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

Lane	NULL
C	NULL
,	NULL
normal	NULL
individual	NULL
platelet	NULL
membrane	NULL
proteins	NULL
;	NULL
lane	NULL
1	NULL
,	NULL
patient	NULL
1	NULL
platelet	NULL
membrane	NULL
proteins	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
patient	NULL
2	NULL
platelet	NULL
membrane	NULL
proteins	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
patient	NULL
3	NULL
platelet	NULL
membrane	NULL
proteins	NULL
.	NULL

This	NULL
Figure	NULL
is	NULL
typical	NULL
of	NULL
two	NULL
experiments	NULL
.	NULL

Comparative	NULL
expression	NULL
of	NULL
the	NULL
platelet	NULL
97	NULL
kDa	NULL
and	NULL
Rap1	NULL
protein	NULL
phosphorylation	NULL
in	NULL
heart	NULL
failure	NULL
In	NULL
parallel	NULL
,	NULL
we	NULL
looked	NULL
for	NULL
a	NULL
pathological	NULL
model	NULL
in	NULL
which	NULL
to	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
Rapl	NULL
protein	NULL
on	NULL
the	NULL
PL	NULL
/IM	NULL
430-recognizable	NULL
97	NULL
kDa	NULL
Ca**-ATPase	NULL
,	NULL
and	NULL
tested	NULL
the	NULL
usefulness	NULL
of	NULL
the	NULL
congestive	NULL
heart	NULL
failure	NULL
model	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
screened	NULL
a	NULL
series	NULL
of	NULL
three	NULL
patients	NULL
with	NULL
severe	NULL
heart	NULL
failure	NULL
(	NULL
patients	NULL
1	NULL
,	NULL
2	NULL
and	NULL
3	NULL
)	NULL
for	NULL
their	NULL
expression	NULL
of	NULL
the	NULL
97	NULL
kDa	NULL
Ca*-ATPase	NULL
and	NULL
their	NULL
exogenous	NULL
phosphorylation	NULL
of	NULL
the	NULL
Rapl	NULL
protein	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
we	NULL
isolated	NULL
mixed	NULL
platelet	NULL
membranes	NULL
(	NULL
100000	NULL
g	NULL
fraction	NULL
)	NULL
[	NULL
8,16	NULL
]	NULL
and	NULL
performed	NULL
,	NULL
in	NULL
parallel	NULL
,	NULL
Western	NULL
blotting	NULL
experiments	NULL
using	NULL
the	NULL
PL	NULL
/IM	NULL
430	NULL
purified	NULL
monoclonal	NULL
antibody	NULL
and	NULL
Rapl	NULL
protein	NULL
phosphorylation	NULL
using	NULL
C	NULL
.	NULL

Sub	NULL
.	NULL

,	NULL
both	NULL
technical	NULL
approaches	NULL
being	NULL
well	NULL
documented	NULL
[	NULL
8,16,18,28,38	NULL
]	NULL
.	NULL

Figure	NULL
3	NULL
shows	NULL
the	NULL
comparative	NULL
results	NULL
of	NULL
such	NULL
experiments	NULL
performed	NULL
on	NULL
three	NULL
patients	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
and	NULL
one	NULL
normal	NULL
individual	NULL
(	NULL
lane	NULL
C	NULL
)	NULL
.	NULL

Figure	NULL
3	NULL
(	NULL
a	NULL
)	NULL
shows	NULL
the	NULL
results	NULL
of	NULL
the	NULL
Western	NULL
blottings	NULL
of	NULL
the	NULL
97	NULL
kDa	NULL
Ca®**-ATPase	NULL
,	NULL
whereas	NULL
Figure	NULL
3	NULL
(	NULL
b	NULL
)	NULL
shows	NULL
the	NULL
Rapl	NULL
protein	NULL
phosphorylation	NULL
obtained	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
lanes	NULL
+	NULL
)	NULL
or	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lanes	NULL
-	NULL
)	NULL
of	NULL
15	NULL
ug/ml	NULL
C.	NULL
Sub	NULL
.	NULL

We	NULL
can	NULL
see	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
97	NULL
kDa	NULL
Ca®**-ATPase	NULL
protein	NULL
(	NULL
Figure	NULL
3a	NULL
)	NULL
was	NULL
present	NULL
in	NULL
the	NULL
platelet	NULL
membranes	NULL
isolated	NULL
from	NULL
a	NULL
normal	NULL
individual	NULL
and	NULL
the	NULL
patients	NULL
,	NULL
in	NULL
spite	NULL
of	NULL
some	NULL
possible	NULL
variations	NULL
between	NULL
individuals	NULL
.	NULL

Figure	NULL
3	NULL
(	NULL
b	NULL
)	NULL
shows	NULL
that	NULL
the	NULL
specific	NULL
Rapi	NULL
protein	NULL
phosphorylation	NULL
in	NULL
the	NULL
platelet	NULL
membranes	NULL
isolated	NULL
from	NULL
the	NULL
same	NULL
patients	NULL
differed	NULL
because	NULL
,	NULL
when	NULL
compared	NULL
with	NULL
the	NULL
normal	NULL
individual	NULL
,	NULL
it	NULL
appeared	NULL
similar	NULL
in	NULL
patient	NULL
3	NULL
,	NULL
but	NULL
higher	NULL
in	NULL
patient	NULL
2	NULL
and	NULL
lower	NULL
in	NULL
patient	NULL
1	NULL
.	NULL

Moreover	NULL
,	NULL
while	NULL
the	NULL
Rapl	NULL
protein	NULL
phosphorylation	NULL
in	NULL
patients	NULL
2	NULL
and	NULL
3	NULL
could	NULL
also	NULL
refer	NULL
to	NULL
Rapt	NULL
protein	NULL
and	NULL
Ca	NULL
#	NULL
+*	NULL
fluxes	NULL
in	NULL
platelets	NULL
473	NULL
some	NULL
variations	NULL
between	NULL
individuals	NULL
,	NULL
the	NULL
striking	NULL
decrease	NULL
in	NULL
Rapl	NULL
phosphorylation	NULL
found	NULL
in	NULL
patient	NULL
1	NULL
clearly	NULL
by-passed	NULL
this	NULL
variation	NULL
.	NULL

So	NULL
,	NULL
this	NULL
first	NULL
examination	NULL
seemed	NULL
encouraging	NULL
to	NULL
us	NULL
,	NULL
as	NULL
it	NULL
provided	NULL
an	NULL
opportunity	NULL
of	NULL
testing	NULL
a	NULL
cell	NULL
system	NULL
showing	NULL
a	NULL
modulation	NULL
of	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
Rapl	NULL
protein	NULL
.	NULL

Correlation	NULL
between	NULL
Rap1	NULL
protein	NULL
expression	NULL
,	NULL
phosphorylation	NULL
and	NULL
stimulation	NULL
of	NULL
Ca*+	NULL
transport	NULL
in	NULL
platelets	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
severe	NULL
heart	NULL
failure	NULL
These	NULL
data	NULL
prompted	NULL
us	NULL
to	NULL
immediately	NULL
test	NULL
the	NULL
effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

on	NULL
the	NULL
Ca®*	NULL
transport	NULL
system	NULL
described	NULL
in	NULL
Figure	NULL
2	NULL
in	NULL
platelet	NULL
membrane	NULL
vesicles	NULL
isolated	NULL
from	NULL
one	NULL
patient	NULL
(	NULL
patient	NULL
4	NULL
)	NULL
with	NULL
severe	NULL
dilated	NULL
cardiomyopathy	NULL
,	NULL
and	NULL
we	NULL
studied	NULL
in	NULL
parallel	NULL
these	NULL
platelets	NULL
for	NULL
Rapl	NULL
protein	NULL
phosphorylation	NULL
and	NULL
the	NULL
effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

on	NULL
Ca**	NULL
uptake	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
because	NULL
the	NULL
apparent	NULL
decrease	NULL
in	NULL
exogenous	NULL
phosphorylation	NULL
of	NULL
the	NULL
Rapl1	NULL
platelet	NULL
protein	NULL
could	NULL
be	NULL
due	NULL
either	NULL
to	NULL
a	NULL
variation	NULL
in	NULL
the	NULL
endogenous	NULL
phosphorylation	NULL
or	NULL
to	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
Rapl	NULL
protein	NULL
expression	NULL
,	NULL
we	NULL
also	NULL
used	NULL
platelets	NULL
from	NULL
this	NULL
patient	NULL
to	NULL
study	NULL
comparatively	NULL
Rapl	NULL
protein	NULL
expression	NULL
and	NULL
phosphorylation	NULL
in	NULL
order	NULL
to	NULL
discriminate	NULL
between	NULL
the	NULL
two	NULL
alternatives	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Comparative	NULL
Rap1	NULL
protein	NULL
phosphorylation	NULL
and	NULL
expression	NULL
Mixed	NULL
100000	NULL
g	NULL
platelet	NULL
membranes	NULL
were	NULL
isolated	NULL
and	NULL
treated	NULL
either	NULL
for	NULL
Rapl	NULL
protein	NULL
phosphorylation	NULL
as	NULL
in	NULL
Figure	NULL
3	NULL
(	NULL
b	NULL
)	NULL
or	NULL
for	NULL
Rapl	NULL
protein	NULL
expression	NULL
by	NULL
Western	NULL
blotting	NULL
using	NULL
a	NULL
previously	NULL
well-characterized	NULL
anti-Rapl	NULL
antibody	NULL
,	NULL
clearly	NULL
shown	NULL
to	NULL
recognize	NULL
specifically	NULL
platelet	NULL
Rapl	NULL
protein	NULL
by	NULL
both	NULL
Western	NULL
blotting	NULL
and	NULL
immunoprecipitation	NULL
[	NULL
16,38	NULL
]	NULL
.	NULL

The	NULL
results	NULL
of	NULL
these	NULL
experiments	NULL
are	NULL
presented	NULL
in	NULL
Figures	NULL
4	NULL
(	NULL
a	NULL
)	NULL
and	NULL
4	NULL
(	NULL
b	NULL
)	NULL
respectively	NULL
.	NULL

Clearly	NULL
,	NULL
a	NULL
strong	NULL
decrease	NULL
in	NULL
Rapl	NULL
protein	NULL
phosphorylation	NULL
(	NULL
which	NULL
appears	NULL
here	NULL
as	NULL
a	NULL
doublet	NULL
band	NULL
due	NULL
to	NULL
incomplete	NULL
reduction	NULL
)	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
platelet	NULL
membranes	NULL
isolated	NULL
from	NULL
this	NULL
patient	NULL
(	NULL
lane	NULL
4+	NULL
)	NULL
as	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
the	NULL
platelet	NULL
membranes	NULL
of	NULL
the	NULL
normal	NULL
individual	NULL
(	NULL
lane	NULL
C+	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
Rapl	NULL
protein	NULL
phosphorylation	NULL
was	NULL
not	NULL
null	NULL
,	NULL
because	NULL
some	NULL
residual	NULL
Rapl	NULL
protein	NULL
phosphorylation	NULL
was	NULL
visible	NULL
on	NULL
this	NULL
Figure	NULL
(	NULL
for	NULL
which	NULL
we	NULL
deliberately	NULL
used	NULL
longer	NULL
autoradiographic	NULL
exposure	NULL
times	NULL
than	NULL
those	NULL
used	NULL
in	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

The	NULL
further	NULL
examination	NULL
of	NULL
the	NULL
Rapl	NULL
protein	NULL
expression	NULL
in	NULL
the	NULL
platelets	NULL
from	NULL
the	NULL
same	NULL
patient	NULL
(	NULL
Figure	NULL
4b	NULL
)	NULL
established	NULL
that	NULL
this	NULL
decrease	NULL
appeared	NULL
well	NULL
correlated	NULL
with	NULL
its	NULL
phosphorylation	NULL
,	NULL
as	NULL
it	NULL
drastically	NULL
decreased	NULL
(	NULL
compare	NULL
lane	NULL
4	NULL
to	NULL
lane	NULL
C	NULL
)	NULL
.	NULL

So	NULL
,	NULL
the	NULL
most	NULL
plausible	NULL
explanation	NULL
for	NULL
the	NULL
decrease	NULL
in	NULL
Rapl	NULL
protein	NULL
phosphorylation	NULL
is	NULL
that	NULL
it	NULL
referred	NULL
to	NULL
a	NULL
lower	NULL
Rapl	NULL
protein	NULL
expression	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
analysis	NULL
of	NULL
the	NULL
97	NULL
kDa	NULL
Ca®*-ATPase	NULL
expression	NULL
in	NULL
the	NULL
same	NULL
patient	NULL
again	NULL
showed	NULL
no	NULL
marked	NULL
difference	NULL
compared	NULL
with	NULL
the	NULL
platelets	NULL
from	NULL
the	NULL
normal	NULL
individual	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Comparative	NULL
effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

on	NULL
Ca	NULL
``	NULL
*	NULL
uptake	NULL
into	NULL
membrane	NULL
vesicles	NULL
The	NULL
results	NULL
,	NULL
presented	NULL
in	NULL
Figure	NULL
4	NULL
(	NULL
c	NULL
)	NULL
,	NULL
show	NULL
the	NULL
comparative	NULL
time	NULL
courses	NULL
of	NULL
Ca**	NULL
uptake	NULL
into	NULL
the	NULL
membrane	NULL
vesicles	NULL
isolated	NULL
from	NULL
platelets	NULL
of	NULL
the	NULL
same	NULL
normal	NULL
individual	NULL
and	NULL
patient	NULL
4	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
15	NULL
ug/ml	NULL
C.	NULL
Sub	NULL
.	NULL

It	NULL
is	NULL
clear	NULL
that	NULL
whereas	NULL
similar	NULL
low	NULL
Ca®*	NULL
uptake	NULL
was	NULL
visualizable	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
C	NULL
.	NULL

Sub	NULL
.	NULL

,	NULL
the	NULL
effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

was	NULL
greatly	NULL
decreased	NULL
in	NULL
membrane	NULL
vesicles	NULL
isolated	NULL
from	NULL
platelets	NULL
of	NULL
this	NULL
patient	NULL
.	NULL

Indeed	NULL
,	NULL
in	NULL
contrast	NULL
with	NULL
platelet	NULL
membrane	NULL
vesicles	NULL
isolated	NULL
from	NULL
a	NULL
normal	NULL
individual	NULL
,	NULL
no	NULL
significant	NULL
effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

was	NULL
detectable	NULL
at	NULL
10	NULL
min	NULL
.	NULL

Also	NULL
,	NULL
the	NULL
very	NULL
low	NULL
expression	NULL
of	NULL
Rapl	NULL
protein	NULL
in	NULL
platelet	NULL
(	NULL
a	NULL
)	NULL
(	NULL
b	NULL
)	NULL
‘	NULL
<	NULL
-	NULL
24	NULL
kDa	NULL
-	NULL
»	NULL
f	NULL
W	NULL
-m	NULL
80	NULL
Ca®*	NULL
uptake	NULL
(	NULL
nmol/mg	NULL
of	NULL
protein	NULL
)	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
Figure	NULL
4	NULL
-	NULL
Comparative	NULL
Rap1	NULL
protein	NULL
phosphorylation	NULL
,	NULL
expression	NULL
and	NULL
effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

on	NULL
Ca**	NULL
uptake	NULL
in	NULL
platelet	NULL
membranes	NULL
isolated	NULL
from	NULL
a	NULL
normal	NULL
Individual	NULL
and	NULL
a	NULL
patient	NULL
with	NULL
severe	NULL
heart	NULL
failure	NULL
Mixed	NULL
platelet	NULL
membrane	NULL
fractions	NULL
(	NULL
100.000	NULL
g	NULL
pellet	NULL
)	NULL
were	NULL
isolated	NULL
from	NULL
a	NULL
normal	NULL
individual	NULL
and	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
severe	NULL
congestive	NULL
heart	NULL
failure	NULL
.	NULL

They	NULL
were	NULL
then	NULL
treated	NULL
in	NULL
parallel	NULL
either	NULL
for	NULL
Rap1	NULL
protein	NULL
phosphorylation	NULL
,	NULL
Rapt	NULL
protein	NULL
expression	NULL
or	NULL
for	NULL
Ca*	NULL
uptake	NULL
measurements	NULL
.	NULL

(	NULL
@	NULL
)	NULL
Cyclic	NULL
AMP-induced	NULL
Rap1	NULL
protein	NULL
phosphorylation	NULL
.	NULL

Platelet	NULL
membrane	NULL
proteins	NULL
(	NULL
50	NULL
g	NULL
)	NULL
were	NULL
phosphorylated	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
lanes	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
lanes	NULL
-	NULL
)	NULL
of	NULL
15	NULL
g/m	NULL
!	NULL

of	NULL
the	NULL
catalytic	NULL
subunit	NULL
of	NULL
cyclic	NULL
AMP-dependent	NULL
protein	NULL
kinase	NULL
under	NULL
the	NULL
conditions	NULL
described	NULL
in	NULL
the	NULL
Experimental	NULL
section	NULL
and	NULL
previously	NULL
used	NULL
in	NULL
Figure	NULL
3	NULL
.	NULL

Reactions	NULL
were	NULL
stopped	NULL
,	NULL
phosphorylated	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS/15	NULL
%	NULL
-PAGE	NULL
,	NULL
electrotransferred	NULL
on	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
and	NULL
autoradiographed	NULL
for	NULL
8	NULL
days	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

Lane	NULL
C	NULL
,	NULL
normal	NULL
individual	NULL
platelet	NULL
membrane	NULL
proteins	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
patient	NULL
4	NULL
platelet	NULL
membrane	NULL
proteins	NULL
.	NULL

The	NULL
Figure	NULL
is	NULL
typical	NULL
of	NULL
two	NULL
experiments	NULL
.	NULL

(	NULL
b	NULL
)	NULL
immunodetection	NULL
of	NULL
the	NULL
platelet	NULL
Rap1	NULL
protein	NULL
.	NULL

Platelet	NULL
membrane	NULL
proteins	NULL
(	NULL
50	NULL
g	NULL
)	NULL
were	NULL
isolated	NULL
,	NULL
electrophoresed	NULL
on	NULL
SDS/15	NULL
%	NULL
-PAGE	NULL
gels	NULL
and	NULL
electroblotted	NULL
as	NULL
in	NULL
Figure	NULL
3	NULL
.	NULL

Nitrocellulose	NULL
membranes	NULL
were	NULL
blocked	NULL
in	NULL
TBS	NULL
(	NULL
10	NULL
mM	NULL
Tris/HC	NULL
!	NULL

,	NULL
pH	NULL
7.5	NULL
,	NULL
0.15	NULL
M	NULL
NaCl	NULL
)	NULL
containing	NULL
5	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
non-fat	NULL
dry	NULL
milk	NULL
,	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
1	NULL
h	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
a	NULL
1	NULL
:100	NULL
dilution	NULL
of	NULL
anti-Rap1	NULL
serum	NULL
in	NULL
TBS	NULL
containing	NULL
0.5	NULL
%	NULL
non-fat	NULL
milk	NULL
for	NULL
2	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
this	NULL
step	NULL
,	NULL
the	NULL
nitrocellulose	NULL
membranes	NULL
were	NULL
washed	NULL
five	NULL
times	NULL
with	NULL
distilled	NULL
water	NULL
and	NULL
then	NULL
with	NULL
TBS	NULL
and	NULL
0.1	NULL
%	NULL
Tween	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Antibody	NULL
binding	NULL
was	NULL
revealed	NULL
by	NULL
1	NULL
h	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
of	NULL
the	NULL
nitrocellulose	NULL
membranes	NULL
with	NULL
``	NULL
``	NULL
I-labelled	NULL
Protein	NULL
A	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Experimental	NULL
section	NULL
.	NULL

Autoradiography	NULL
of	NULL
the	NULL
dried	NULL
nitrocellulose	NULL
membrane	NULL
was	NULL
performed	NULL
for	NULL
1	NULL
day	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

Lane	NULL
C	NULL
,	NULL
normal	NULL
individual	NULL
platelet	NULL
membrane	NULL
proteins	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
patient	NULL
4	NULL
platelet	NULL
membrane	NULL
proteins	NULL
.	NULL

This	NULL
Figure	NULL
is	NULL
typical	NULL
of	NULL
two	NULL
experiments	NULL
.	NULL

(	NULL
e	NULL
)	NULL
Effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

on	NULL
Ca*uptake	NULL
into	NULL
membrane	NULL
vesicles	NULL
.	NULL

Mixed	NULL
membrane	NULL
vesicles	NULL
were	NULL
incubated	NULL
and	NULL
treated	NULL
for	NULL
uptake	NULL
measurements	NULL
under	NULL
the	NULL
conditions	NULL
of	NULL
Figure	NULL
2	NULL
.	NULL

@	NULL
,	NULL
uptake	NULL
by	NULL
control	NULL
platelet	NULL
membrane	NULL
vesicles	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
C	NULL
.	NULL

Sub	NULL
.	NULL

;	NULL
BWW	NULL
,	NULL
Ca	NULL
``	NULL
*	NULL
uptake	NULL
by	NULL
control	NULL
platelet	NULL
membrane	NULL
vesicles	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
15	NULL
g/m	NULL
!	NULL

C	NULL
.	NULL

Sub	NULL
.	NULL

;	NULL
O	NULL
,	NULL
uptake	NULL
by	NULL
patient	NULL
4	NULL
platelet	NULL
membrane	NULL
vesicles	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
C	NULL
.	NULL

Sub	NULL
.	NULL

;	NULL
[	NULL
C	NULL
]	NULL
,	NULL
Ca	NULL
``	NULL
*	NULL
uptake	NULL
by	NULL
patient	NULL
4	NULL
platelet	NULL
membrane	NULL
vesicles	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
15	NULL
g/m	NULL
!	NULL

C.	NULL
Sub	NULL
.	NULL

This	NULL
Figure	NULL
is	NULL
typical	NULL
of	NULL
two	NULL
experiments	NULL
.	NULL

membranes	NULL
of	NULL
this	NULL
patient	NULL
appeared	NULL
to	NULL
correlate	NULL
with	NULL
a	NULL
further	NULL
delay	NULL
in	NULL
the	NULL
response	NULL
towards	NULL
C	NULL
.	NULL

Sub	NULL
.	NULL

,	NULL
which	NULL
only	NULL
became	NULL
detectable	NULL
at	NULL
20	NULL
min	NULL
and	NULL
remained	NULL
considerably	NULL
decreased	NULL
.	NULL

So	NULL
again	NULL
,	NULL
phosphate	NULL
ions	NULL
,	NULL
present	NULL
in	NULL
similar	NULL
amounts	NULL
in	NULL
the	NULL
different	NULL
samples	NULL
,	NULL
obviously	NULL
are	NULL
not	NULL
the	NULL
sole	NULL
factor	NULL
responsible	NULL
for	NULL
stimulation	NULL
of	NULL
Ca**	NULL
uptake	NULL
.	NULL

474	NULL
C.	NULL
Magnier	NULL
and	NULL
others	NULL
(	NULL
%	NULL
of	NULL
Control	NULL
)	NULL
®	NULL
0	NULL
transport	NULL
PL	NULL
|	NULL
w	NULL
/	NULL
>	NULL
VCaZ	NULL
‘	NULL
et	NULL
/	NULL
,	NULL
/	NULL
y	NULL
Rap1	NULL
expression	NULL
Figure	NULL
5	NULL
-	NULL
Comparative	NULL
Rap1	NULL
protein	NULL
expression	NULL
and	NULL
effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

on	NULL
Ca**	NULL
uptake	NULL
in	NULL
platelet	NULL
membranes	NULL
isolated	NULL
from	NULL
a	NULL
further	NULL
series	NULL
of	NULL
patients	NULL
with	NULL
heart	NULL
failure	NULL
Rap	NULL
1	NULL
protein	NULL
expression	NULL
:	NULL
platelet	NULL
membranes	NULL
were	NULL
isolated	NULL
from	NULL
a	NULL
normal	NULL
individual	NULL
and	NULL
from	NULL
different	NULL
patients	NULL
with	NULL
heart	NULL
failure	NULL
.	NULL

Membrane	NULL
proteins	NULL
(	NULL
50	NULL
ag	NULL
)	NULL
were	NULL
separated	NULL
on	NULL
SDS/15	NULL
%	NULL
-PAGE	NULL
,	NULL
electroblotted	NULL
,	NULL
and	NULL
treated	NULL
for	NULL
Western	NULL
blotting	NULL
and	NULL
immunodetection	NULL
as	NULL
in	NULL
Figure	NULL
4	NULL
(	NULL
b	NULL
)	NULL
.	NULL

The	NULL
intensities	NULL
of	NULL
immunoreactive	NULL
bands	NULL
were	NULL
estimated	NULL
by	NULL
densitometric	NULL
measurements	NULL
using	NULL
a	NULL
laser	NULL
densitometer	NULL
.	NULL

For	NULL
each	NULL
experiment	NULL
,	NULL
the	NULL
control	NULL
values	NULL
obtained	NULL
for	NULL
Rapi	NULL
protein	NULL
expression	NULL
in	NULL
normal	NULL
platelets	NULL
were	NULL
arbitrarily	NULL
taken	NULL
as	NULL
100	NULL
%	NULL
.	NULL

The	NULL
results	NULL
(	NULL
bars	NULL
5	NULL
to	NULL
7	NULL
)	NULL
are	NULL
expressed	NULL
as	NULL
percentages	NULL
of	NULL
Rap1	NULL
protein	NULL
expression	NULL
versus	NULL
the	NULL
control	NULL
(	NULL
bar	NULL
C	NULL
)	NULL
.	NULL

Bars	NULL
5	NULL
to	NULL
7	NULL
correspond	NULL
to	NULL
platelet	NULL
membranes	NULL
isolated	NULL
from	NULL
patients	NULL
5	NULL
,	NULL
6	NULL
and	NULL
7	NULL
respectively	NULL
.	NULL

Effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

on	NULL
Ca®+	NULL
uptake	NULL
into	NULL
membrane	NULL
vesicles	NULL
:	NULL
mixed	NULL
platelet	NULL
membrane	NULL
vesicles	NULL
were	NULL
incubated	NULL
and	NULL
treated	NULL
for	NULL
Ca	NULL
``	NULL
+*	NULL
uptake	NULL
measurements	NULL
up	NULL
to	NULL
30	NULL
min	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
15	NULL
g/m	NULL
!	NULL

C.	NULL
Sub	NULL
.	NULL

under	NULL
the	NULL
conditions	NULL
of	NULL
Figure	NULL
4	NULL
(	NULL
c	NULL
)	NULL
.	NULL

For	NULL
each	NULL
experiment	NULL
,	NULL
the	NULL
control	NULL
values	NULL
obtained	NULL
for	NULL
C.	NULL
Sub.-induced	NULL
stimulation	NULL
of	NULL
Ca**	NULL
uptake	NULL
into	NULL
normal	NULL
individual	NULL
platelet	NULL
membrane	NULL
vesicles	NULL
were	NULL
arbitrarily	NULL
taken	NULL
as	NULL
100	NULL
%	NULL
.	NULL

The	NULL
results	NULL
(	NULL
bars	NULL
5	NULL
to	NULL
7	NULL
)	NULL
are	NULL
expressed	NULL
as	NULL
percentages	NULL
of	NULL
C.	NULL
Sub.-induced	NULL
stimulation	NULL
of	NULL
Ca	NULL
#	NULL
*	NULL
uptake	NULL
versus	NULL
the	NULL
control	NULL
(	NULL
bar	NULL
C	NULL
)	NULL
.	NULL

Bars	NULL
5	NULL
to	NULL
7	NULL
correspond	NULL
to	NULL
platelet	NULL
membranes	NULL
isolated	NULL
from	NULL
patients	NULL
5	NULL
,	NULL
6	NULL
and	NULL
7	NULL
respectively	NULL
.	NULL

Correlation	NULL
between	NULL
the	NULL
Rap1	NULL
protein	NULL
levels	NULL
and	NULL
the	NULL
stimulation	NULL
of	NULL
Ca®+	NULL
uptake	NULL
in	NULL
a	NULL
further	NULL
series	NULL
of	NULL
patients	NULL
with	NULL
heart	NULL
failure	NULL
Finally	NULL
,	NULL
we	NULL
studied	NULL
another	NULL
series	NULL
of	NULL
three	NULL
different	NULL
patients	NULL
with	NULL
characterized	NULL
heart	NULL
failure	NULL
,	NULL
and	NULL
tested	NULL
in	NULL
parallel	NULL
their	NULL
platelet	NULL
membranes	NULL
for	NULL
Rapl	NULL
protein	NULL
expression	NULL
and	NULL
the	NULL
effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

on	NULL
Ca**	NULL
uptake	NULL
,	NULL
for	NULL
which	NULL
we	NULL
used	NULL
the	NULL
experimental	NULL
conditions	NULL
of	NULL
Figure	NULL
4	NULL
(	NULL
b	NULL
)	NULL
and	NULL
Figure	NULL
2	NULL
respectively	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
expressions	NULL
of	NULL
Rapl	NULL
proteins	NULL
were	NULL
estimated	NULL
by	NULL
densitometric	NULL
measurements	NULL
of	NULL
the	NULL
radioactive	NULL
bands	NULL
from	NULL
the	NULL
same	NULL
immuno-blots	NULL
and	NULL
were	NULL
expressed	NULL
as	NULL
percentages	NULL
of	NULL
Rapl	NULL
protein	NULL
expression	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
the	NULL
normal	NULL
individual	NULL
.	NULL

The	NULL
results	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
15	NULL
ug/ml	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

on	NULL
the	NULL
Ca®*	NULL
uptake	NULL
by	NULL
platelet	NULL
membrane	NULL
vesicles	NULL
from	NULL
the	NULL
same	NULL
patients	NULL
were	NULL
expressed	NULL
as	NULL
percentages	NULL
of	NULL
the	NULL
stimulation	NULL
observed	NULL
at	NULL
30	NULL
min	NULL
.	NULL

Figure	NULL
5	NULL
shows	NULL
the	NULL
results	NULL
of	NULL
these	NULL
studies	NULL
conducted	NULL
on	NULL
the	NULL
same	NULL
day	NULL
.	NULL

Clearly	NULL
,	NULL
the	NULL
analysis	NULL
of	NULL
these	NULL
data	NULL
allows	NULL
the	NULL
conclusion	NULL
that	NULL
this	NULL
last	NULL
study	NULL
:	NULL
(	NULL
i	NULL
)	NULL
confirmed	NULL
the	NULL
results	NULL
presented	NULL
in	NULL
Figure	NULL
3	NULL
obtained	NULL
using	NULL
a	NULL
first	NULL
series	NULL
of	NULL
patients	NULL
,	NULL
because	NULL
the	NULL
platelet	NULL
Rapl	NULL
protein	NULL
expressions	NULL
can	NULL
be	NULL
decreased	NULL
in	NULL
patients	NULL
with	NULL
heart	NULL
failure	NULL
,	NULL
and	NULL
that	NULL
this	NULL
decrease	NULL
varied	NULL
greatly	NULL
,	NULL
in	NULL
that	NULL
it	NULL
did	NULL
not	NULL
exceed	NULL
20	NULL
%	NULL
in	NULL
patient	NULL
5	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
but	NULL
reached	NULL
about	NULL
60	NULL
%	NULL
in	NULL
patient	NULL
7	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
demonstrated	NULL
the	NULL
direct	NULL
relationship	NULL
between	NULL
these	NULL
variable	NULL
expressions	NULL
of	NULL
Rapl	NULL
protein	NULL
and	NULL
the	NULL
stimulatory	NULL
effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

on	NULL
Ca®**	NULL
uptake	NULL
.	NULL

Thus	NULL
,	NULL
this	NULL
so	NULL
far	NULL
undescribed	NULL
opportunity	NULL
of	NULL
testing	NULL
pathological	NULL
platelets	NULL
which	NULL
express	NULL
abnormal	NULL
and	NULL
variable	NULL
Rapl	NULL
protein	NULL
levels	NULL
constitutes	NULL
a	NULL
further	NULL
argument	NULL
for	NULL
the	NULL
close	NULL
relationship	NULL
between	NULL
the	NULL
phosphorylation	NULL
of	NULL
this	NULL
protein	NULL
and	NULL
the	NULL
regulatory	NULL
effect	NULL
on	NULL
platelet	NULL
Ca**	NULL
transport	NULL
.	NULL

DISCUSSION	NULL
This	NULL
paper	NULL
first	NULL
describes	NULL
an	NULL
abnormality	NULL
in	NULL
the	NULL
Rapl	NULL
protein	NULL
expression	NULL
and	NULL
phosphorylation	NULL
in	NULL
platelets	NULL
from	NULL
patients	NULL
with	NULL
heart	NULL
failure	NULL
,	NULL
and	NULL
secondly	NULL
establishes	NULL
a	NULL
correlation	NULL
between	NULL
this	NULL
abnormality	NULL
and	NULL
the	NULL
stimulatory	NULL
effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

on	NULL
Ca**	NULL
uptake	NULL
by	NULL
membrane	NULL
vesicles	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
first	NULL
essential	NULL
feature	NULL
of	NULL
this	NULL
work	NULL
is	NULL
that	NULL
it	NULL
suggested	NULL
a	NULL
new	NULL
way	NULL
to	NULL
investigate	NULL
the	NULL
relationship	NULL
between	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
platelet	NULL
Rapl	NULL
protein	NULL
and	NULL
stimulation	NULL
of	NULL
Ca*	NULL
uptake	NULL
by	NULL
intracellular	NULL
Ca**-ATPases	NULL
.	NULL

Indeed	NULL
,	NULL
as	NULL
explained	NULL
in	NULL
the	NULL
Introduction	NULL
,	NULL
a	NULL
controversy	NULL
was	NULL
raised	NULL
,	NULL
based	NULL
on	NULL
an	NULL
artefactual	NULL
effect	NULL
of	NULL
C	NULL
.	NULL

Sub	NULL
.	NULL

,	NULL
although	NULL
these	NULL
findings	NULL
did	NULL
not	NULL
take	NULL
into	NULL
account	NULL
similar	NULL
results	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
cyclic	NULL
AMP	NULL
on	NULL
stimulation	NULL
of	NULL
the	NULL
Ca®*	NULL
transport	NULL
process	NULL
,	NULL
examined	NULL
by	NULL
approaches	NULL
on	NULL
intact	NULL
platelets	NULL
which	NULL
did	NULL
not	NULL
involve	NULL
the	NULL
C.	NULL
Sub	NULL
.	NULL

[	NULL
11,12,21	NULL
]	NULL
.	NULL

Also	NULL
,	NULL
it	NULL
did	NULL
not	NULL
consider	NULL
the	NULL
fact	NULL
that	NULL
there	NULL
is	NULL
increasing	NULL
evidence	NULL
that	NULL
all	NULL
the	NULL
different	NULL
mechanisms	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cytosolic	NULL
Ca**	NULL
concentration	NULL
,	NULL
such	NULL
as	NULL
Ca**	NULL
channels	NULL
[	NULL
39	NULL
]	NULL
,	NULL
plasma	NULL
membrane-type	NULL
Ca**-ATPase	NULL
[	NULL
40	NULL
]	NULL
,	NULL
the	NULL
intracellular	NULL
SERCA	NULL
1	NULL
isoform	NULL
of	NULL
Ca**-ATPase	NULL
[	NULL
41	NULL
]	NULL
,	NULL
and	NULL
the	NULL
InsP	NULL
,	NULL
-induced	NULL
Ca®**	NULL
release	NULL
[	NULL
42	NULL
]	NULL
,	NULL
are	NULL
regulated	NULL
by	NULL
cyclic	NULL
AMP	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
studied	NULL
a	NULL
cell	NULL
system	NULL
with	NULL
variable	NULL
expression	NULL
of	NULL
the	NULL
Rapl	NULL
protein	NULL
and	NULL
phosphorylation	NULL
and	NULL
showed	NULL
a	NULL
correlation	NULL
between	NULL
a	NULL
down-regulation	NULL
of	NULL
Rap1	NULL
protein	NULL
and	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
effect	NULL
of	NULL
cyclic	NULL
AMP	NULL
to	NULL
regulate	NULL
Ca®**	NULL
uptake	NULL
.	NULL

Moreover	NULL
,	NULL
and	NULL
interestingly	NULL
,	NULL
these	NULL
findings	NULL
are	NULL
just	NULL
complementary	NULL
to	NULL
our	NULL
recent	NULL
study	NULL
of	NULL
another	NULL
platelet	NULL
pathology	NULL
,	NULL
where	NULL
we	NULL
found	NULL
an	NULL
increase	NULL
in	NULL
Ca®*	NULL
uptake	NULL
associated	NULL
with	NULL
an	NULL
increase	NULL
in	NULL
endogenous	NULL
Rap	NULL
!	NULL

protein	NULL
phosphorylation	NULL
,	NULL
in	NULL
studies	NULL
conducted	NULL
without	NULL
using	NULL
C	NULL
.	NULL

Sub	NULL
.	NULL

,	NULL
i.e	NULL
.	NULL

where	NULL
contaminating	NULL
phosphate	NULL
was	NULL
absent	NULL
[	NULL
38	NULL
]	NULL
.	NULL

So	NULL
,	NULL
our	NULL
present	NULL
interpretation	NULL
of	NULL
the	NULL
controversy	NULL
is	NULL
as	NULL
follows	NULL
:	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
studies	NULL
using	NULL
C.	NULL
Sub	NULL
.	NULL

in	NULL
phosphate	NULL
buffer	NULL
measured	NULL
phosphate-	NULL
and/or	NULL
C.	NULL
Sub.-induced	NULL
phosphorylation	NULL
effectively	NULL
could	NULL
raise	NULL
the	NULL
problem	NULL
of	NULL
the	NULL
difficulty	NULL
of	NULL
dissociating	NULL
the	NULL
two	NULL
effects	NULL
.	NULL

However	NULL
,	NULL
first	NULL
,	NULL
one	NULL
approach	NULL
used	NULL
to	NULL
solve	NULL
this	NULL
question	NULL
was	NULL
to	NULL
proceed	NULL
with	NULL
the	NULL
dialysis	NULL
of	NULL
C	NULL
.	NULL

Sub	NULL
.	NULL

,	NULL
but	NULL
we	NULL
failed	NULL
to	NULL
maintain	NULL
full	NULL
phosphorylation	NULL
after	NULL
this	NULL
step	NULL
(	NULL
Figure	NULL
la	NULL
)	NULL
.	NULL

Secondly	NULL
,	NULL
a	NULL
consensus	NULL
does	NULL
exist	NULL
between	NULL
authors	NULL
to	NULL
show	NULL
that	NULL
platelet	NULL
Rapl1	NULL
protein	NULL
is	NULL
phosphorylated	NULL
by	NULL
the	NULL
C.	NULL
Sub	NULL
.	NULL

Thirdly	NULL
,	NULL
the	NULL
unmasking	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
C.	NULL
Sub	NULL
.	NULL

depends	NULL
upon	NULL
the	NULL
experimental	NULL
conditions	NULL
(	NULL
not	NULL
detectable	NULL
or	NULL
transient	NULL
in	NULL
Ca**	NULL
uptake	NULL
studies	NULL
without	NULL
Ca®*-EGTA	NULL
buffers	NULL
)	NULL
and	NULL
it	NULL
appears	NULL
here	NULL
as	NULL
a	NULL
condition	NULL
for	NULL
Ca**	NULL
uptake	NULL
,	NULL
such	NULL
as	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
phospholamban	NULL
in	NULL
the	NULL
cardiac	NULL
SERCA	NULL
2	NULL
isoform	NULL
,	NULL
because	NULL
in	NULL
its	NULL
dephosphorylated	NULL
form	NULL
phospholamban	NULL
inhibits	NULL
Ca®**	NULL
uptake	NULL
,	NULL
but	NULL
it	NULL
allows	NULL
Ca®*	NULL
uptake	NULL
in	NULL
its	NULL
phosphorylated	NULL
form	NULL
[	NULL
43	NULL
]	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
present	NULL
study	NULL
largely	NULL
confirms	NULL
the	NULL
relationship	NULL
between	NULL
the	NULL
phosphorylation	NULL
of	NULL
Rapl	NULL
platelet	NULL
protein	NULL
and	NULL
the	NULL
stimulation	NULL
of	NULL
Ca**	NULL
transport	NULL
.	NULL

However	NULL
,	NULL
this	NULL
new	NULL
evidence	NULL
for	NULL
a	NULL
relationship	NULL
between	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
platelet	NULL
Rapl	NULL
protein	NULL
and	NULL
the	NULL
stimulation	NULL
of	NULL
Ca®*	NULL
transport	NULL
could	NULL
raise	NULL
the	NULL
question	NULL
of	NULL
the	NULL
location	NULL
of	NULL
the	NULL
proteins	NULL
involved	NULL
.	NULL

Indeed	NULL
,	NULL
as	NULL
regards	NULL
the	NULL
platelet	NULL
Rapl	NULL
protein	NULL
,	NULL
literature	NULL
data	NULL
,	NULL
including	NULL
our	NULL
investigation	NULL
after	NULL
cell	NULL
fraction-ation	NULL
,	NULL
establish	NULL
its	NULL
association	NULL
with	NULL
plasma	NULL
membranes	NULL
[	NULL
15	NULL
17,44,45	NULL
]	NULL
.	NULL

In	NULL
apparent	NULL
contrast	NULL
,	NULL
the	NULL
97	NULL
kDa	NULL
platelet	NULL
Ca**-ATPase	NULL
,	NULL
which	NULL
is	NULL
recognized	NULL
by	NULL
PL/IM	NULL
430	NULL
,	NULL
reacts	NULL
with	NULL
a	NULL
monoclonal	NULL
antibody	NULL
raised	NULL
against	NULL
intracellular	NULL
platelet	NULL
membranes	NULL
;	NULL
so	NULL
,	NULL
the	NULL
question	NULL
of	NULL
a	NULL
plasma	NULL
membrane	NULL
association	NULL
is	NULL
raised	NULL
.	NULL

Never-theless	NULL
,	NULL
the	NULL
technique	NULL
used	NULL
to	NULL
obtain	NULL
these	NULL
membranes	NULL
involved	NULL
Rap1	NULL
protein	NULL
and	NULL
fluxes	NULL
in	NULL
platelets	NULL
475	NULL
neuraminidase	NULL
treatment	NULL
which	NULL
can	NULL
result	NULL
in	NULL
some	NULL
platelet	NULL
activation	NULL
,	NULL
i.e	NULL
.	NULL

a	NULL
redistribution	NULL
of	NULL
organelles	NULL
,	NULL
such	NULL
as	NULL
the	NULL
migration	NULL
of	NULL
Ca**	NULL
pools	NULL
located	NULL
next	NULL
to	NULL
the	NULL
plasma	NULL
membrane	NULL
facing	NULL
the	NULL
intracellular	NULL
space	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
this	NULL
hypothesis	NULL
,	NULL
the	NULL
results	NULL
of	NULL
preliminary	NULL
experiments	NULL
suggest	NULL
a	NULL
translocation	NULL
of	NULL
the	NULL
PL	NULL
/IM	NULL
430-recognizable	NULL
97	NULL
kDa	NULL
Ca**-ATPase	NULL
from	NULL
plasma	NULL
membranes	NULL
towards	NULL
intracellular	NULL
membranes	NULL
upon	NULL
platelet	NULL
activation	NULL
(	NULL
G.	NULL
Berger	NULL
,	NULL
T.	NULL
Kovacs	NULL
,	NULL
E.	NULL
Corvazier	NULL
,	NULL
J.	NULL
Enouf	NULL
and	NULL
E.	NULL
Martin-Cramer	NULL
,	NULL
unpublished	NULL
work	NULL
)	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
,	NULL
even	NULL
if	NULL
a	NULL
co-location	NULL
still	NULL
remains	NULL
to	NULL
be	NULL
established	NULL
,	NULL
the	NULL
available	NULL
data	NULL
can	NULL
not	NULL
eliminate	NULL
the	NULL
relationship	NULL
between	NULL
the	NULL
platelet	NULL
Rapl	NULL
protein	NULL
and	NULL
PL/IM	NULL
430-recognizable	NULL
Ca®*-ATPase	NULL
,	NULL
based	NULL
on	NULL
different	NULL
locations	NULL
of	NULL
the	NULL
proteins	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
other	NULL
essential	NULL
feature	NULL
of	NULL
this	NULL
work	NULL
concerns	NULL
the	NULL
evidence	NULL
for	NULL
abnormal	NULL
platelet	NULL
Rapl	NULL
protein	NULL
expression	NULL
in	NULL
congestive	NULL
heart	NULL
failure	NULL
.	NULL

Rapl	NULL
proteins	NULL
were	NULL
recently	NULL
described	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
[	NULL
46	NULL
]	NULL
,	NULL
and	NULL
the	NULL
study	NULL
of	NULL
their	NULL
roles	NULL
is	NULL
still	NULL
under	NULL
investigation	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
we	NULL
know	NULL
very	NULL
little	NULL
about	NULL
the	NULL
regulation	NULL
of	NULL
their	NULL
expression	NULL
in	NULL
cell	NULL
functions	NULL
,	NULL
especially	NULL
in	NULL
haematopoietic	NULL
cells	NULL
such	NULL
as	NULL
platelets	NULL
which	NULL
,	NULL
intriguingly	NULL
,	NULL
over-express	NULL
this	NULL
type	NULL
of	NULL
protein	NULL
.	NULL

The	NULL
present	NULL
finding	NULL
of	NULL
the	NULL
down-regulation	NULL
of	NULL
Rapl	NULL
expression	NULL
,	NULL
well	NULL
established	NULL
here	NULL
by	NULL
both	NULL
Western	NULL
blotting	NULL
using	NULL
a	NULL
specific	NULL
anti-peptide	NULL
antibody	NULL
and	NULL
its	NULL
phosphorylation	NULL
,	NULL
is	NULL
particularly	NULL
interesting	NULL
because	NULL
it	NULL
constitutes	NULL
,	NULL
as	NULL
far	NULL
as	NULL
we	NULL
know	NULL
,	NULL
the	NULL
first	NULL
example	NULL
of	NULL
down-regulation	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
platelet	NULL
Rapl	NULL
protein	NULL
.	NULL

Indeed	NULL
,	NULL
our	NULL
previous	NULL
investigations	NULL
in	NULL
this	NULL
context	NULL
led	NULL
us	NULL
to	NULL
observe	NULL
up-regulation	NULL
of	NULL
Rapl1	NULL
protein	NULL
in	NULL
the	NULL
two	NULL
different	NULL
pathological	NULL
models	NULL
studied	NULL
,	NULL
associated	NULL
with	NULL
an	NULL
increase	NULL
in	NULL
cytosolic	NULL
Ca**	NULL
concentration	NULL
,	NULL
namely	NULL
in	NULL
platelets	NULL
from	NULL
hypertensive	NULL
rats	NULL
[	NULL
18	NULL
]	NULL
and	NULL
on	NULL
proliferation	NULL
of	NULL
smooth-muscle	NULL
cells	NULL
induced	NULL
by	NULL
a	NULL
growth	NULL
factor	NULL
,	NULL
the	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
[	NULL
30	NULL
]	NULL
.	NULL

So	NULL
,	NULL
interestingly	NULL
,	NULL
Rapl	NULL
proteins	NULL
appear	NULL
to	NULL
be	NULL
up-regulated	NULL
in	NULL
pathological	NULL
situations	NULL
associated	NULL
with	NULL
an	NULL
increase	NULL
in	NULL
cytosolic	NULL
Ca®*	NULL
,	NULL
but	NULL
in	NULL
heart	NULL
failure	NULL
this	NULL
type	NULL
of	NULL
protein	NULL
appears	NULL
to	NULL
be	NULL
down-regulated	NULL
,	NULL
as	NULL
are	NULL
cardiac	NULL
f-adrenergic	NULL
receptors	NULL
which	NULL
lead	NULL
to	NULL
a	NULL
decrease	NULL
in	NULL
cyclic	NULL
AMP	NULL
concentration	NULL
.	NULL

Thus	NULL
the	NULL
present	NULL
study	NULL
still	NULL
emphasizes	NULL
the	NULL
interrelation	NULL
between	NULL
the	NULL
two	NULL
messengers	NULL
constituted	NULL
by	NULL
Ca**	NULL
ions	NULL
and	NULL
cyclic	NULL
AMP	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Professor	NULL
N.	NULL
Crawford	NULL
(	NULL
London	NULL
)	NULL
for	NULL
generously	NULL
supplying	NULL
the	NULL
PL/IM	NULL
430	NULL
hybridoma	NULL
cells	NULL
and	NULL
to	NULL
Dr.	NULL
J.	NULL
de	NULL
Gunzburg	NULL
(	NULL
Paris	NULL
)	NULL
for	NULL
kindly	NULL
giving	NULL
us	NULL
the	NULL
Rap1	NULL
antibody	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Anne	NULL
Marie	NULL
Lompré	NULL
for	NULL
her	NULL
help	NULL
in	NULL
this	NULL
investigation	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
mainly	NULL
by	NULL
INSERM	NULL
and	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
sur	NULL
le	NULL
Cancer	NULL
,	NULL
the	NULL
Comité	NULL
de	NULL
Paris	NULL
de	NULL
la	NULL
Ligue	NULL
Nationale	NULL
contre	NULL
le	NULL
Cancer	NULL
,	NULL
the	NULL
Association	NULL
Francaise	NULL
contre	NULL
les	NULL
Myopathies	NULL
and	NULL
the	NULL
Ministére	NULL
des	NULL
Affaires	NULL
Etrangéres	NULL
.	NULL

REFERENCES	NULL
1	NULL
Rink	NULL
,	NULL
T.	NULL
J.	NULL
and	NULL
Sage	NULL
,	NULL
S.	NULL
0	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Physiol	NULL
.	NULL

§2	NULL
,	NULL
431-449	NULL
2	NULL
-	NULL
Bring	NULL
,	NULL
B.	NULL
and	NULL
Ullrich	NULL
,	NULL
V.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
19232-19237	NULL
3	NULL
-	NULL
Tao	NULL
,	NULL
J.	NULL
and	NULL
Haynes	NULL
,	NULL
D.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
24972-24982	NULL
4	NULL
-	NULL
Heemskerk	NULL
,	NULL
J.	NULL
W.	NULL
M.	NULL
,	NULL
Vis	NULL
,	NULL
P.	NULL
,	NULL
Feige	NULL
,	NULL
M.	NULL
A.	NULL
H.	NULL
,	NULL
Hoyland	NULL
,	NULL
J.	NULL
,	NULL
Mason	NULL
,	NULL
W.	NULL
T.	NULL
and	NULL
Sage	NULL
,	NULL
S.	NULL
0	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
356-363	NULL
5	NULL
-	NULL
Enouf	NULL
,	NULL
J.	NULL
,	NULL
Bredoux	NULL
,	NULL
R.	NULL
,	NULL
Papp	NULL
,	NULL
B.	NULL
,	NULL
Dijaffar	NULL
,	NULL
1.	NULL
,	NULL
Lompré	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Kieffer	NULL
,	NULL
N.	NULL
,	NULL
Gayet	NULL
,	NULL
0.	NULL
,	NULL
Clemetson	NULL
,	NULL
K.	NULL
,	NULL
Wuytack	NULL
,	NULL
F.	NULL
and	NULL
Rosa	NULL
,	NULL
J.	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

286	NULL
,	NULL
135-140	NULL
6	NULL
-	NULL
Bobe	NULL
,	NULL
R.	NULL
,	NULL
Bredoux	NULL
,	NULL
R.	NULL
,	NULL
Wuytack	NULL
,	NULL
F.	NULL
,	NULL
Quarck	NULL
,	NULL
R.	NULL
,	NULL
Kovacs	NULL
,	NULL
T.	NULL
,	NULL
Papp	NULL
,	NULL
B.	NULL
,	NULL
Corvazier	NULL
,	NULL
E.	NULL
,	NULL
Magnier	NULL
,	NULL
C.	NULL
and	NULL
Enouf	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
1417-1424	NULL
7	NULL
Wuytack	NULL
,	NULL
F.	NULL
,	NULL
Papp	NULL
,	NULL
B.	NULL
,	NULL
Verboomen	NULL
,	NULL
H.	NULL
,	NULL
Ragymaekers	NULL
,	NULL
L.	NULL
,	NULL
Dode	NULL
,	NULL
L.	NULL
,	NULL
Bobe	NULL
,	NULL
R.	NULL
,	NULL
Enouf	NULL
,	NULL
J.	NULL
,	NULL
Bokkala	NULL
,	NULL
S.	NULL
,	NULL
Authi	NULL
,	NULL
K.	NULL
S.	NULL
and	NULL
Casteels	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
1410-1416	NULL
Received	NULL
30	NULL
August	NULL
1994/7	NULL
April	NULL
1995	NULL
;	NULL
accepted	NULL
25	NULL
April	NULL
1995	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
21	NULL
22	NULL
23	NULL
25	NULL
26	NULL
28	NULL
29	NULL
30	NULL
31	NULL
33	NULL
34	NULL
35	NULL
36	NULL
37	NULL
39	NULL
40	NULL
41	NULL
42	NULL
43	NULL
45	NULL
46	NULL
Kovacs	NULL
,	NULL
T.	NULL
,	NULL
Corvazier	NULL
,	NULL
E.	NULL
,	NULL
Papp	NULL
,	NULL
B.	NULL
,	NULL
Magnier	NULL
,	NULL
C.	NULL
,	NULL
Bredoux	NULL
,	NULL
R.	NULL
,	NULL
Enyedi	NULL
,	NULL
A.	NULL
,	NULL
Sarkadi	NULL
,	NULL
B.	NULL
and	NULL
Enouf	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
6177-6184	NULL
Waldmann	NULL
,	NULL
R.	NULL
,	NULL
Bauer	NULL
,	NULL
S.	NULL
,	NULL
Gobet	NULL
,	NULL
C.	NULL
,	NULL
Hofmann	NULL
,	NULL
F.	NULL
,	NULL
Jakobs	NULL
,	NULL
K.	NULL
H.	NULL
and	NULL
Walter	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

158	NULL
,	NULL
203-210	NULL
Eigenthaler	NULL
,	NULL
M.	NULL
,	NULL
Nolte	NULL
,	NULL
C.	NULL
,	NULL
Halbriigge	NULL
,	NULL
M.	NULL
and	NULL
Walter	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

205	NULL
,	NULL
471-481	NULL
Kaser-Glanzmann	NULL
,	NULL
R.	NULL
,	NULL
Jakabova	NULL
,	NULL
M.	NULL
,	NULL
George	NULL
,	NULL
J.	NULL
N.	NULL
and	NULL
Luscher	NULL
,	NULL
E.	NULL
F.	NULL
(	NULL
1977	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
466	NULL
,	NULL
429-440	NULL
Fox	NULL
,	NULL
J.	NULL
E.	NULL
B.	NULL
,	NULL
Say	NULL
,	NULL
A.	NULL
K.	NULL
and	NULL
Haslam	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

184	NULL
,	NULL
651-661	NULL
Adunyah	NULL
,	NULL
S.	NULL
E.	NULL
and	NULL
Dean	NULL
,	NULL
W.	NULL
L.	NULL
(	NULL
1987	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
930	NULL
,	NULL
401-419	NULL
Hettash	NULL
,	NULL
J.	NULL
M.	NULL
and	NULL
Le	NULL
Breton	NULL
,	NULL
G.	NULL
C.	NULL
(	NULL
1987	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

159	NULL
,	NULL
644-650	NULL
Fischer	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
Gatting	NULL
,	NULL
M.	NULL
N.	NULL
,	NULL
Lacal	NULL
,	NULL
J.-C.	NULL
and	NULL
White	NULL
,	NULL
G.	NULL
C.	NULL
,	NULL
II	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
19405-19408	NULL
Corvazier	NULL
,	NULL
E.	NULL
,	NULL
Enout	NULL
,	NULL
J.	NULL
,	NULL
Papp	NULL
,	NULL
B.	NULL
,	NULL
de	NULL
Gunzburg	NULL
,	NULL
J.	NULL
,	NULL
Tavitian	NULL
,	NULL
A.	NULL
and	NULL
Lévy-Tolédano	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

281	NULL
,	NULL
325-331	NULL
Torti	NULL
,	NULL
M.	NULL
and	NULL
Lapetina	NULL
,	NULL
E.	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
89	NULL
,	NULL
7796-7800	NULL
Magnier	NULL
,	NULL
C.	NULL
,	NULL
Bredoux	NULL
,	NULL
R.	NULL
,	NULL
Kovacs	NULL
,	NULL
T.	NULL
,	NULL
Quarck	NULL
,	NULL
R.	NULL
,	NULL
Papp	NULL
,	NULL
B.	NULL
,	NULL
Corvazier	NULL
,	NULL
E.	NULL
,	NULL
de	NULL
Gunzburg	NULL
,	NULL
J.	NULL
and	NULL
Enout	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

297	NULL
,	NULL
343-350	NULL
O'Rourke	NULL
,	NULL
F.	NULL
,	NULL
Zavoico	NULL
,	NULL
G.	NULL
B.	NULL
and	NULL
Feinstein	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

257	NULL
,	NULL
715-721	NULL
White	NULL
,	NULL
G.	NULL
C.	NULL
,	NULL
11	NULL
,	NULL
Barton	NULL
,	NULL
D.	NULL
,	NULL
White	NULL
,	NULL
T.	NULL
E.	NULL
and	NULL
Fischer	NULL
,	NULL
T.	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
Thromb	NULL
.	NULL

Res	NULL
.	NULL

56	NULL
,	NULL
575-581	NULL
Johansson	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Nied	NULL
,	NULL
L.	NULL
E.	NULL
and	NULL
Haynes	NULL
,	NULL
D.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1105	NULL
,	NULL
19-28	NULL
Bristow	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Ginsburg	NULL
,	NULL
R.	NULL
,	NULL
Umans	NULL
,	NULL
V.	NULL
,	NULL
Fowler	NULL
,	NULL
M.	NULL
,	NULL
Minobe	NULL
,	NULL
W.	NULL
,	NULL
Rasmussen	NULL
,	NULL
R.	NULL
,	NULL
Zera	NULL
,	NULL
P.	NULL
,	NULL
Menlove	NULL
,	NULL
R.	NULL
,	NULL
Shah	NULL
,	NULL
P.	NULL
,	NULL
Jamieson	NULL
,	NULL
S.	NULL
and	NULL
Stinson	NULL
,	NULL
E.	NULL
B	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Circ	NULL
.	NULL

Res	NULL
.	NULL

59	NULL
,	NULL
297-309	NULL
Weiss	NULL
,	NULL
R.	NULL
J.	NULL
and	NULL
Smith	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
J	NULL
.	NULL

Am	NULL
.	NULL

Coll	NULL
.	NULL

Cardiol	NULL
.	NULL

2	NULL
,	NULL
631-638	NULL
Enouf	NULL
,	NULL
J.	NULL
,	NULL
Bredoux	NULL
,	NULL
R.	NULL
,	NULL
Boizard	NULL
,	NULL
B.	NULL
,	NULL
Wautier	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Chap	NULL
,	NULL
H.	NULL
,	NULL
Thomas	NULL
,	NULL
J.	NULL
,	NULL
de	NULL
Metz	NULL
,	NULL
M.	NULL
and	NULL
Lévy-Tolédano	NULL
,	NULL
S.	NULL
(	NULL
1984	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

123	NULL
,	NULL
50-58	NULL
Enouf	NULL
,	NULL
J.	NULL
,	NULL
Bredoux	NULL
,	NULL
R.	NULL
,	NULL
Bourdeau	NULL
,	NULL
N.	NULL
and	NULL
Lévy-Tolédano	NULL
,	NULL
S.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262	NULL
,	NULL
9293-9297	NULL
Bradford	NULL
,	NULL
M.	NULL
M.	NULL
(	NULL
1976	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

72	NULL
,	NULL
248-254	NULL
Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
(	NULL
1970	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
227	NULL
,	NULL
680-685	NULL
Enouf	NULL
,	NULL
J.	NULL
,	NULL
Bredoux	NULL
,	NULL
R.	NULL
,	NULL
Boucheix	NULL
,	NULL
C.	NULL
,	NULL
Mirshahi	NULL
,	NULL
M.	NULL
,	NULL
Soria	NULL
,	NULL
C.	NULL
and	NULL
Lévy-Tolédanc	NULL
,	NULL
S.	NULL
(	NULL
1985	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

183	NULL
,	NULL
398-402	NULL
Béranger	NULL
,	NULL
F.	NULL
,	NULL
Goud	NULL
,	NULL
B.	NULL
,	NULL
Tavitian	NULL
,	NULL
A.	NULL
and	NULL
de	NULL
Gunzburg	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
88	NULL
,	NULL
1606-1610	NULL
Quarck	NULL
,	NULL
R.	NULL
,	NULL
Bryckaert	NULL
,	NULL
M.	NULL
,	NULL
Magnier	NULL
,	NULL
C.	NULL
,	NULL
Corvazier	NULL
,	NULL
E.	NULL
,	NULL
Bredoux	NULL
,	NULL
R.	NULL
,	NULL
de	NULL
Gunzburg	NULL
,	NULL
J.	NULL
,	NULL
Fontenay	NULL
,	NULL
M.	NULL
,	NULL
Tobelem	NULL
,	NULL
G.	NULL
and	NULL
Enouf	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

342	NULL
,	NULL
159-164	NULL
Hack	NULL
,	NULL
N.	NULL
,	NULL
Wilkinson	NULL
,	NULL
J.	NULL
M.	NULL
and	NULL
Crawford	NULL
,	NULL
N.	NULL
(	NULL
1988	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

250	NULL
,	NULL
355-361	NULL
Papp	NULL
,	NULL
B.	NULL
,	NULL
Enyedi	NULL
,	NULL
A.	NULL
,	NULL
Paszty	NULL
,	NULL
K.	NULL
,	NULL
Kovacs	NULL
,	NULL
T.	NULL
,	NULL
Sarkadi	NULL
,	NULL
B.	NULL
,	NULL
Gardos	NULL
,	NULL
G.	NULL
,	NULL
Magnier	NULL
,	NULL
C.	NULL
,	NULL
Wuytack	NULL
,	NULL
F.	NULL
and	NULL
Enouf	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

288	NULL
,	NULL
297-302	NULL
Fabiato	NULL
,	NULL
A.	NULL
and	NULL
Fabiato	NULL
,	NULL
F.	NULL
(	NULL
1979	NULL
)	NULL
J.	NULL
Physiol	NULL
.	NULL

(	NULL
Paris	NULL
)	NULL
75	NULL
,	NULL
463-505	NULL
Enouf	NULL
,	NULL
J.	NULL
,	NULL
Bredoux	NULL
,	NULL
R.	NULL
,	NULL
Bourdeau	NULL
,	NULL
N.	NULL
,	NULL
Sarkadi	NULL
,	NULL
B.	NULL
and	NULL
Lévy-Tolédano	NULL
,	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

263	NULL
,	NULL
547-552	NULL
Darnanville	NULL
,	NULL
A.	NULL
,	NULL
Bredoux	NULL
,	NULL
R.	NULL
,	NULL
Clemetson	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Kieffer	NULL
,	NULL
N.	NULL
,	NULL
Bourdeau	NULL
,	NULL
N.	NULL
,	NULL
Lévy-Tolédano	NULL
,	NULL
S.	NULL
,	NULL
Caen	NULL
,	NULL
J.	NULL
P.	NULL
and	NULL
Enouf	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

273	NULL
,	NULL
429-434	NULL
Papp	NULL
,	NULL
B.	NULL
,	NULL
Paszty	NULL
,	NULL
K.	NULL
,	NULL
Kovacs	NULL
,	NULL
T.	NULL
,	NULL
Sarkadi	NULL
,	NULL
B.	NULL
,	NULL
Gardos	NULL
,	NULL
G.	NULL
,	NULL
Enouf	NULL
,	NULL
J.	NULL
and	NULL
Enyedi	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Celi	NULL
Calcium	NULL
14	NULL
,	NULL
531-538	NULL
Siess	NULL
,	NULL
W.	NULL
and	NULL
Lapetina	NULL
,	NULL
E.	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

271	NULL
,	NULL
815-819	NULL
Enouf	NULL
,	NULL
J.	NULL
,	NULL
Corvazier	NULL
,	NULL
E.	NULL
,	NULL
Papp	NULL
,	NULL
B.	NULL
,	NULL
Quarck	NULL
,	NULL
R.	NULL
,	NULL
Magnier	NULL
,	NULL
C.	NULL
,	NULL
Kovacs	NULL
,	NULL
T.	NULL
,	NULL
Bredoux	NULL
,	NULL
R.	NULL
,	NULL
Lévy-Tolédano	NULL
,	NULL
S.	NULL
,	NULL
de	NULL
Gunzburg	NULL
,	NULL
J.	NULL
,	NULL
Wuytack	NULL
,	NULL
F.	NULL
and	NULL
Caen	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Br	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

86	NULL
,	NULL
338-346	NULL
Scutptoreanu	NULL
,	NULL
A.	NULL
,	NULL
Scheuer	NULL
,	NULL
T.	NULL
and	NULL
Catterall	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
364	NULL
,	NULL
240-243	NULL
Carafoli	NULL
,	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
2115-2118	NULL
James	NULL
,	NULL
P.	NULL
,	NULL
Inui	NULL
,	NULL
M.	NULL
,	NULL
Tada	NULL
,	NULL
M.	NULL
,	NULL
Chiesi	NULL
,	NULL
M.	NULL
and	NULL
Carafoli	NULL
,	NULL
E.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
342	NULL
,	NULL
90-92	NULL
Supattapone	NULL
,	NULL
S.	NULL
,	NULL
Danoff	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Theibert	NULL
,	NULL
A.	NULL
,	NULL
Joseph	NULL
,	NULL
S.	NULL
,	NULL
Steiner	NULL
,	NULL
J.	NULL
and	NULL
Snyder	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
85	NULL
,	NULL
8747-8750	NULL
Kirchberger	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Borchman	NULL
,	NULL
D.	NULL
and	NULL
Kasinathan	NULL
,	NULL
C.	NULL
(	NULL
1986	NULL
)	NULL
Biochemistry	NULL
25	NULL
,	NULL
5484-5492	NULL
Berger	NULL
,	NULL
G.	NULL
,	NULL
Quarck	NULL
,	NULL
R.	NULL
,	NULL
Tenza	NULL
,	NULL
D.	NULL
,	NULL
Lévy-Tolédano	NULL
,	NULL
S.	NULL
,	NULL
de	NULL
Gunzburg	NULL
,	NULL
J.	NULL
and	NULL
Martin-Cramer	NULL
,	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
Br	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

88	NULL
,	NULL
372-382	NULL
White	NULL
,	NULL
G.	NULL
C.	NULL
,	NULL
!	NULL

I	NULL
,	NULL
Crawford	NULL
,	NULL
N.	NULL
and	NULL
Fischer	NULL
,	NULL
T.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
Adv	NULL
.	NULL

Exp	NULL
.	NULL

Biol	NULL
.	NULL

Med	NULL
.	NULL

344	NULL
,	NULL
187-194	NULL
Farrell	NULL
,	NULL
F.	NULL
,	NULL
Torti	NULL
,	NULL
M.	NULL
and	NULL
Lapetina	NULL
,	NULL
E.	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
J	NULL
.	NULL

Lab	NULL
.	NULL

Clin	NULL
.	NULL

Med	NULL
.	NULL

120	NULL
,	NULL
533-537	NULL

